#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=A Method to Compare the Discriminatory Power of Data-driven Methods: Application to ICA and IVA Background: The widespread application of data-driven factorization-based methods, such as independent component analysis (ICA), to functional magnetic resonance imaging data facilitates the study of neural function and how it is disrupted by psychiatric disorders such as schizophrenia.
1-1	0-1	A	_
1-2	2-8	Method	_
1-3	9-11	to	_
1-4	12-19	Compare	_
1-5	20-23	the	_
1-6	24-38	Discriminatory	_
1-7	39-44	Power	_
1-8	45-47	of	_
1-9	48-59	Data-driven	_
1-10	60-67	Methods	_
1-11	68-69	:	_
1-12	70-81	Application	_
1-13	82-84	to	_
1-14	85-88	ICA	_
1-15	89-92	and	_
1-16	93-96	IVA	_
1-17	97-107	Background	_
1-18	108-109	:	_
1-19	110-113	The	_
1-20	114-124	widespread	_
1-21	125-136	application	_
1-22	137-139	of	_
1-23	140-151	data-driven	_
1-24	152-171	factorization-based	_
1-25	172-179	methods	_
1-26	180-181	,	_
1-27	182-186	such	_
1-28	187-189	as	_
1-29	190-201	independent	_
1-30	202-211	component	_
1-31	212-220	analysis	_
1-32	221-222	(	_
1-33	223-226	ICA	_
1-34	227-228	)	_
1-35	229-230	,	_
1-36	231-233	to	_
1-37	234-244	functional	_
1-38	245-253	magnetic	_
1-39	254-263	resonance	_
1-40	264-271	imaging	_
1-41	272-276	data	_
1-42	277-288	facilitates	_
1-43	289-292	the	_
1-44	293-298	study	_
1-45	299-301	of	_
1-46	302-308	neural	_
1-47	309-317	function	_
1-48	318-321	and	_
1-49	322-325	how	_
1-50	326-328	it	_
1-51	329-331	is	_
1-52	332-341	disrupted	_
1-53	342-344	by	_
1-54	345-356	psychiatric	_
1-55	357-366	disorders	_
1-56	367-371	such	_
1-57	372-374	as	_
1-58	375-388	schizophrenia	_
1-59	389-390	.	_

Text=While the increasing number of these methods motivates a comparison of their relative performance, such a comparison is difficult to perform on real fMRI data, since the ground truth is, relatively, unknown and the alignment of factors across different methods is impractical and imprecise.
2-1	391-396	While	_
2-2	397-400	the	_
2-3	401-411	increasing	_
2-4	412-418	number	_
2-5	419-421	of	_
2-6	422-427	these	_
2-7	428-435	methods	_
2-8	436-445	motivates	_
2-9	446-447	a	_
2-10	448-458	comparison	_
2-11	459-461	of	_
2-12	462-467	their	_
2-13	468-476	relative	_
2-14	477-488	performance	_
2-15	489-490	,	_
2-16	491-495	such	_
2-17	496-497	a	_
2-18	498-508	comparison	_
2-19	509-511	is	_
2-20	512-521	difficult	_
2-21	522-524	to	_
2-22	525-532	perform	_
2-23	533-535	on	_
2-24	536-540	real	_
2-25	541-545	fMRI	_
2-26	546-550	data	_
2-27	551-552	,	_
2-28	553-558	since	_
2-29	559-562	the	_
2-30	563-569	ground	_
2-31	570-575	truth	_
2-32	576-578	is	_
2-33	579-580	,	_
2-34	581-591	relatively	_
2-35	592-593	,	_
2-36	594-601	unknown	_
2-37	602-605	and	_
2-38	606-609	the	_
2-39	610-619	alignment	_
2-40	620-622	of	_
2-41	623-630	factors	_
2-42	631-637	across	_
2-43	638-647	different	_
2-44	648-655	methods	_
2-45	656-658	is	_
2-46	659-670	impractical	_
2-47	671-674	and	_
2-48	675-684	imprecise	_
2-49	685-686	.	_

Text=New Method: We present a novel method, global difference maps (GDMs), to compare the results of different fMRI analysis techniques on real fMRI data, quantify their relative performances, and highlight the differences between the decompositions visually.
3-1	687-690	New	_
3-2	691-697	Method	_
3-3	698-699	:	_
3-4	700-702	We	_
3-5	703-710	present	_
3-6	711-712	a	_
3-7	713-718	novel	_
3-8	719-725	method	_
3-9	726-727	,	_
3-10	728-734	global	_
3-11	735-745	difference	_
3-12	746-750	maps	_
3-13	751-752	(	_
3-14	753-757	GDMs	_
3-15	758-759	)	_
3-16	760-761	,	_
3-17	762-764	to	_
3-18	765-772	compare	_
3-19	773-776	the	_
3-20	777-784	results	_
3-21	785-787	of	_
3-22	788-797	different	_
3-23	798-802	fMRI	_
3-24	803-811	analysis	_
3-25	812-822	techniques	_
3-26	823-825	on	_
3-27	826-830	real	_
3-28	831-835	fMRI	_
3-29	836-840	data	_
3-30	841-842	,	_
3-31	843-851	quantify	_
3-32	852-857	their	_
3-33	858-866	relative	_
3-34	867-879	performances	_
3-35	880-881	,	_
3-36	882-885	and	_
3-37	886-895	highlight	_
3-38	896-899	the	_
3-39	900-911	differences	_
3-40	912-919	between	_
3-41	920-923	the	_
3-42	924-938	decompositions	_
3-43	939-947	visually	_
3-44	948-949	.	_

Text=Comparison with Existing Methods: We apply this method to compare the performances of two different factorization-based methods, ICA and its multiset extension independent vector analysis (IVA), for the analysis of fMRI data from 109 patients with schizophrenia and 138 healthy controls during the performance of three tasks.
4-1	950-960	Comparison	_
4-2	961-965	with	_
4-3	966-974	Existing	_
4-4	975-982	Methods	_
4-5	983-984	:	_
4-6	985-987	We	_
4-7	988-993	apply	_
4-8	994-998	this	_
4-9	999-1005	method	_
4-10	1006-1008	to	_
4-11	1009-1016	compare	_
4-12	1017-1020	the	_
4-13	1021-1033	performances	_
4-14	1034-1036	of	_
4-15	1037-1040	two	_
4-16	1041-1050	different	_
4-17	1051-1070	factorization-based	_
4-18	1071-1078	methods	_
4-19	1079-1080	,	_
4-20	1081-1084	ICA	_
4-21	1085-1088	and	_
4-22	1089-1092	its	_
4-23	1093-1101	multiset	_
4-24	1102-1111	extension	_
4-25	1112-1123	independent	_
4-26	1124-1130	vector	_
4-27	1131-1139	analysis	_
4-28	1140-1141	(	_
4-29	1142-1145	IVA	_
4-30	1146-1147	)	_
4-31	1148-1149	,	_
4-32	1150-1153	for	_
4-33	1154-1157	the	_
4-34	1158-1166	analysis	_
4-35	1167-1169	of	_
4-36	1170-1174	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
4-37	1175-1179	data	_
4-38	1180-1184	from	_
4-39	1185-1188	109	_
4-40	1189-1197	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-41	1198-1202	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-42	1203-1216	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-43	1217-1220	and	_
4-44	1221-1224	138	_
4-45	1225-1232	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-46	1233-1241	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
4-47	1242-1248	during	_
4-48	1249-1252	the	_
4-49	1253-1264	performance	_
4-50	1265-1267	of	_
4-51	1268-1273	three	_
4-52	1274-1279	tasks	_
4-53	1280-1281	.	_

Text=Results: Through this application of GDMs, we find that IVA can determine regions that are more discriminatory between patients and controls than ICA, though IVA is less effective at emphasizing regions found in only a subset of the tasks.
5-1	1282-1289	Results	_
5-2	1290-1291	:	_
5-3	1292-1299	Through	_
5-4	1300-1304	this	_
5-5	1305-1316	application	_
5-6	1317-1319	of	_
5-7	1320-1324	GDMs	_
5-8	1325-1326	,	_
5-9	1327-1329	we	_
5-10	1330-1334	find	_
5-11	1335-1339	that	_
5-12	1340-1343	IVA	_
5-13	1344-1347	can	_
5-14	1348-1357	determine	_
5-15	1358-1365	regions	_
5-16	1366-1370	that	_
5-17	1371-1374	are	_
5-18	1375-1379	more	_
5-19	1380-1394	discriminatory	_
5-20	1395-1402	between	_
5-21	1403-1411	patients	_
5-22	1412-1415	and	_
5-23	1416-1424	controls	_
5-24	1425-1429	than	_
5-25	1430-1433	ICA	_
5-26	1434-1435	,	_
5-27	1436-1442	though	_
5-28	1443-1446	IVA	_
5-29	1447-1449	is	_
5-30	1450-1454	less	_
5-31	1455-1464	effective	_
5-32	1465-1467	at	_
5-33	1468-1479	emphasizing	_
5-34	1480-1487	regions	_
5-35	1488-1493	found	_
5-36	1494-1496	in	_
5-37	1497-1501	only	_
5-38	1502-1503	a	_
5-39	1504-1510	subset	_
5-40	1511-1513	of	_
5-41	1514-1517	the	_
5-42	1518-1523	tasks	_
5-43	1524-1525	.	_

Text=Conclusions: These results demonstrate that GDMs are an effective way to compare the performances of different factorization-based methods as well as regression-based analyses.
6-1	1526-1537	Conclusions	_
6-2	1538-1539	:	_
6-3	1540-1545	These	_
6-4	1546-1553	results	_
6-5	1554-1565	demonstrate	_
6-6	1566-1570	that	_
6-7	1571-1575	GDMs	_
6-8	1576-1579	are	_
6-9	1580-1582	an	_
6-10	1583-1592	effective	_
6-11	1593-1596	way	_
6-12	1597-1599	to	_
6-13	1600-1607	compare	_
6-14	1608-1611	the	_
6-15	1612-1624	performances	_
6-16	1625-1627	of	_
6-17	1628-1637	different	_
6-18	1638-1657	factorization-based	_
6-19	1658-1665	methods	_
6-20	1666-1668	as	_
6-21	1669-1673	well	_
6-22	1674-1676	as	_
6-23	1677-1693	regression-based	_
6-24	1694-1702	analyses	_
6-25	1703-1704	.	_

Text=Materials and Methods Feature Extraction Since the timing of the stimuli in each task is different, it is difficult to jointly analyze multi-task fMRI data.
7-1	1705-1714	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
7-2	1715-1718	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
7-3	1719-1726	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
7-4	1727-1734	Feature	_
7-5	1735-1745	Extraction	_
7-6	1746-1751	Since	_
7-7	1752-1755	the	_
7-8	1756-1762	timing	_
7-9	1763-1765	of	_
7-10	1766-1769	the	_
7-11	1770-1777	stimuli	_
7-12	1778-1780	in	_
7-13	1781-1785	each	_
7-14	1786-1790	task	_
7-15	1791-1793	is	_
7-16	1794-1803	different	_
7-17	1804-1805	,	_
7-18	1806-1808	it	_
7-19	1809-1811	is	_
7-20	1812-1821	difficult	_
7-21	1822-1824	to	_
7-22	1825-1832	jointly	_
7-23	1833-1840	analyze	_
7-24	1841-1851	multi-task	_
7-25	1852-1856	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
7-26	1857-1861	data	_
7-27	1862-1863	.	_

Text=Rather, for each subject, a simple linear regression is run on the data from each voxel using the statistical parametric mapping toolbox (SPM), where the regressors are created by convolving the hemodynamic response function (HRF) in SPM with the desired predictors for each task.
8-1	1864-1870	Rather	_
8-2	1871-1872	,	_
8-3	1873-1876	for	_
8-4	1877-1881	each	_
8-5	1882-1889	subject	_
8-6	1890-1891	,	_
8-7	1892-1893	a	_
8-8	1894-1900	simple	_
8-9	1901-1907	linear	_
8-10	1908-1918	regression	_
8-11	1919-1921	is	_
8-12	1922-1925	run	_
8-13	1926-1928	on	_
8-14	1929-1932	the	_
8-15	1933-1937	data	_
8-16	1938-1942	from	_
8-17	1943-1947	each	_
8-18	1948-1953	voxel	_
8-19	1954-1959	using	_
8-20	1960-1963	the	_
8-21	1964-1975	statistical	_
8-22	1976-1986	parametric	_
8-23	1987-1994	mapping	_
8-24	1995-2002	toolbox	_
8-25	2003-2004	(	_
8-26	2005-2008	SPM	_
8-27	2009-2010	)	_
8-28	2011-2012	,	_
8-29	2013-2018	where	_
8-30	2019-2022	the	_
8-31	2023-2033	regressors	_
8-32	2034-2037	are	_
8-33	2038-2045	created	_
8-34	2046-2048	by	_
8-35	2049-2059	convolving	_
8-36	2060-2063	the	_
8-37	2064-2075	hemodynamic	_
8-38	2076-2084	response	_
8-39	2085-2093	function	_
8-40	2094-2095	(	_
8-41	2096-2099	HRF	_
8-42	2100-2101	)	_
8-43	2102-2104	in	_
8-44	2105-2108	SPM	_
8-45	2109-2113	with	_
8-46	2114-2117	the	_
8-47	2118-2125	desired	_
8-48	2126-2136	predictors	_
8-49	2137-2140	for	_
8-50	2141-2145	each	_
8-51	2146-2150	task	_
8-52	2151-2152	.	_

Text=The resulting regression coefficient maps are used as features for each subject and task.
9-1	2153-2156	The	_
9-2	2157-2166	resulting	_
9-3	2167-2177	regression	_
9-4	2178-2189	coefficient	_
9-5	2190-2194	maps	_
9-6	2195-2198	are	_
9-7	2199-2203	used	_
9-8	2204-2206	as	_
9-9	2207-2215	features	_
9-10	2216-2219	for	_
9-11	2220-2224	each	_
9-12	2225-2232	subject	_
9-13	2233-2236	and	_
9-14	2237-2241	task	_
9-15	2242-2243	.	_

Text=This reduction, using a lower-dimensional though still multivariate representation of the data, facilitates exploration of the associations across the features from multiple tasks, see e.g.,, as well as enabling the identification of intrinsic functional networks.
10-1	2244-2248	This	_
10-2	2249-2258	reduction	_
10-3	2259-2260	,	_
10-4	2261-2266	using	_
10-5	2267-2268	a	_
10-6	2269-2286	lower-dimensional	_
10-7	2287-2293	though	_
10-8	2294-2299	still	_
10-9	2300-2312	multivariate	_
10-10	2313-2327	representation	_
10-11	2328-2330	of	_
10-12	2331-2334	the	_
10-13	2335-2339	data	_
10-14	2340-2341	,	_
10-15	2342-2353	facilitates	_
10-16	2354-2365	exploration	_
10-17	2366-2368	of	_
10-18	2369-2372	the	_
10-19	2373-2385	associations	_
10-20	2386-2392	across	_
10-21	2393-2396	the	_
10-22	2397-2405	features	_
10-23	2406-2410	from	_
10-24	2411-2419	multiple	_
10-25	2420-2425	tasks	_
10-26	2426-2427	,	_
10-27	2428-2431	see	_
10-28	2432-2436	e.g.	_
10-29	2437-2438	,	_
10-30	2439-2440	,	_
10-31	2441-2443	as	_
10-32	2444-2448	well	_
10-33	2449-2451	as	_
10-34	2452-2460	enabling	_
10-35	2461-2464	the	_
10-36	2465-2479	identification	_
10-37	2480-2482	of	_
10-38	2483-2492	intrinsic	_
10-39	2493-2503	functional	_
10-40	2504-2512	networks	_
10-41	2513-2514	.	_

Text=FMRI Tasks and Features The datasets used in this study are from the Mind Research Network Clinical Imaging Consortium Collection (publicly available at http: //coins.mrn.org).
11-1	2515-2519	FMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-2	2520-2525	Tasks	_
11-3	2526-2529	and	_
11-4	2530-2538	Features	_
11-5	2539-2542	The	_
11-6	2543-2551	datasets	_
11-7	2552-2556	used	_
11-8	2557-2559	in	_
11-9	2560-2564	this	_
11-10	2565-2570	study	_
11-11	2571-2574	are	_
11-12	2575-2579	from	_
11-13	2580-2583	the	_
11-14	2584-2588	Mind	_
11-15	2589-2597	Research	_
11-16	2598-2605	Network	_
11-17	2606-2614	Clinical	_
11-18	2615-2622	Imaging	_
11-19	2623-2633	Consortium	_
11-20	2634-2644	Collection	_
11-21	2645-2646	(	_
11-22	2647-2655	publicly	_
11-23	2656-2665	available	_
11-24	2666-2668	at	_
11-25	2669-2673	http	_
11-26	2674-2675	:	_
11-27	2676-2691	//coins.mrn.org	_
11-28	2692-2693	)	_
11-29	2694-2695	.	_

Text=These datasets were obtained from 247 subjects, 109 patients with schizophrenia and 138 healthy controls.
12-1	2696-2701	These	_
12-2	2702-2710	datasets	_
12-3	2711-2715	were	_
12-4	2716-2724	obtained	_
12-5	2725-2729	from	_
12-6	2730-2733	247	_
12-7	2734-2742	subjects	_
12-8	2743-2744	,	_
12-9	2745-2748	109	_
12-10	2749-2757	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-11	2758-2762	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-12	2763-2776	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
12-13	2777-2780	and	_
12-14	2781-2784	138	_
12-15	2785-2792	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-16	2793-2801	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
12-17	2802-2803	.	_

Text=Next, we introduce the tasks as well as the associated multivariate features analyzed in this study.
13-1	2804-2808	Next	_
13-2	2809-2810	,	_
13-3	2811-2813	we	_
13-4	2814-2823	introduce	_
13-5	2824-2827	the	_
13-6	2828-2833	tasks	_
13-7	2834-2836	as	_
13-8	2837-2841	well	_
13-9	2842-2844	as	_
13-10	2845-2848	the	_
13-11	2849-2859	associated	_
13-12	2860-2872	multivariate	_
13-13	2873-2881	features	_
13-14	2882-2890	analyzed	_
13-15	2891-2893	in	_
13-16	2894-2898	this	_
13-17	2899-2904	study	_
13-18	2905-2906	.	_

Text=Auditory Oddball Task This auditory task required the subjects to listen to three different types of auditory stimuli in a pseudo-random order: standard (1 kHz tones occurring with a probability of 0.82), novel (complex sounds occurring with a probability of 0.09), and target (1.2 kHz tones occurring with a probability of 0.09, to which a right thumb button press was required).
14-1	2907-2915	Auditory	http://maven.renci.org/NeuroBridge/neurobridge#AuditoryOddballTask
14-2	2916-2923	Oddball	_
14-3	2924-2928	Task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
14-4	2929-2933	This	_
14-5	2934-2942	auditory	_
14-6	2943-2947	task	_
14-7	2948-2956	required	_
14-8	2957-2960	the	_
14-9	2961-2969	subjects	_
14-10	2970-2972	to	_
14-11	2973-2979	listen	_
14-12	2980-2982	to	_
14-13	2983-2988	three	_
14-14	2989-2998	different	_
14-15	2999-3004	types	_
14-16	3005-3007	of	_
14-17	3008-3016	auditory	_
14-18	3017-3024	stimuli	_
14-19	3025-3027	in	_
14-20	3028-3029	a	_
14-21	3030-3043	pseudo-random	_
14-22	3044-3049	order	_
14-23	3050-3051	:	_
14-24	3052-3060	standard	_
14-25	3061-3062	(	_
14-26	3063-3064	1	_
14-27	3065-3068	kHz	_
14-28	3069-3074	tones	_
14-29	3075-3084	occurring	_
14-30	3085-3089	with	_
14-31	3090-3091	a	_
14-32	3092-3103	probability	_
14-33	3104-3106	of	_
14-34	3107-3111	0.82	_
14-35	3112-3113	)	_
14-36	3114-3115	,	_
14-37	3116-3121	novel	_
14-38	3122-3123	(	_
14-39	3124-3131	complex	_
14-40	3132-3138	sounds	_
14-41	3139-3148	occurring	_
14-42	3149-3153	with	_
14-43	3154-3155	a	_
14-44	3156-3167	probability	_
14-45	3168-3170	of	_
14-46	3171-3175	0.09	_
14-47	3176-3177	)	_
14-48	3178-3179	,	_
14-49	3180-3183	and	_
14-50	3184-3190	target	_
14-51	3191-3192	(	_
14-52	3193-3196	1.2	_
14-53	3197-3200	kHz	_
14-54	3201-3206	tones	_
14-55	3207-3216	occurring	_
14-56	3217-3221	with	_
14-57	3222-3223	a	_
14-58	3224-3235	probability	_
14-59	3236-3238	of	_
14-60	3239-3243	0.09	_
14-61	3244-3245	,	_
14-62	3246-3248	to	_
14-63	3249-3254	which	_
14-64	3255-3256	a	_
14-65	3257-3262	right	_
14-66	3263-3268	thumb	_
14-67	3269-3275	button	_
14-68	3276-3281	press	_
14-69	3282-3285	was	_
14-70	3286-3294	required	_
14-71	3295-3296	)	_
14-72	3297-3298	.	_

Text=Each run of the task consisted of 90 stimuli, each with a 200 ms duration and a randomly changing interstimulus interval of between 550 and 2,050 ms.
15-1	3299-3303	Each	_
15-2	3304-3307	run	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-3	3308-3310	of	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-4	3311-3314	the	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-5	3315-3319	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-6	3320-3329	consisted	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-7	3330-3332	of	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-8	3333-3335	90	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-9	3336-3343	stimuli	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
15-10	3344-3345	,	_
15-11	3346-3350	each	_
15-12	3351-3355	with	_
15-13	3356-3357	a	_
15-14	3358-3361	200	_
15-15	3362-3364	ms	_
15-16	3365-3373	duration	_
15-17	3374-3377	and	_
15-18	3378-3379	a	_
15-19	3380-3388	randomly	_
15-20	3389-3397	changing	_
15-21	3398-3411	interstimulus	_
15-22	3412-3420	interval	_
15-23	3421-3423	of	_
15-24	3424-3431	between	_
15-25	3432-3435	550	_
15-26	3436-3439	and	_
15-27	3440-3445	2,050	_
15-28	3446-3448	ms	_
15-29	3449-3450	.	_

Text=The order of novel and target stimuli was changed between runs, thus ensuring that the responses were not dependent on the stimulus order.
16-1	3451-3454	The	_
16-2	3455-3460	order	_
16-3	3461-3463	of	_
16-4	3464-3469	novel	_
16-5	3470-3473	and	_
16-6	3474-3480	target	_
16-7	3481-3488	stimuli	_
16-8	3489-3492	was	_
16-9	3493-3500	changed	_
16-10	3501-3508	between	_
16-11	3509-3513	runs	_
16-12	3514-3515	,	_
16-13	3516-3520	thus	_
16-14	3521-3529	ensuring	_
16-15	3530-3534	that	_
16-16	3535-3538	the	_
16-17	3539-3548	responses	_
16-18	3549-3553	were	_
16-19	3554-3557	not	_
16-20	3558-3567	dependent	_
16-21	3568-3570	on	_
16-22	3571-3574	the	_
16-23	3575-3583	stimulus	_
16-24	3584-3589	order	_
16-25	3590-3591	.	_

Text=For this task, the regressor was created by modeling both the target and standard stimuli as delta functions and convolving this sequence of delta functions with the default SPM HRF in addition to their temporal derivatives.
17-1	3592-3595	For	_
17-2	3596-3600	this	_
17-3	3601-3605	task	_
17-4	3606-3607	,	_
17-5	3608-3611	the	_
17-6	3612-3621	regressor	_
17-7	3622-3625	was	_
17-8	3626-3633	created	_
17-9	3634-3636	by	_
17-10	3637-3645	modeling	_
17-11	3646-3650	both	_
17-12	3651-3654	the	_
17-13	3655-3661	target	_
17-14	3662-3665	and	_
17-15	3666-3674	standard	_
17-16	3675-3682	stimuli	_
17-17	3683-3685	as	_
17-18	3686-3691	delta	_
17-19	3692-3701	functions	_
17-20	3702-3705	and	_
17-21	3706-3716	convolving	_
17-22	3717-3721	this	_
17-23	3722-3730	sequence	_
17-24	3731-3733	of	_
17-25	3734-3739	delta	_
17-26	3740-3749	functions	_
17-27	3750-3754	with	_
17-28	3755-3758	the	_
17-29	3759-3766	default	_
17-30	3767-3770	SPM	_
17-31	3771-3774	HRF	_
17-32	3775-3777	in	_
17-33	3778-3786	addition	_
17-34	3787-3789	to	_
17-35	3790-3795	their	_
17-36	3796-3804	temporal	_
17-37	3805-3816	derivatives	_
17-38	3817-3818	.	_

Text=Subject averaged contrast images between the target versus the standard tones were used as the feature for this task.
18-1	3819-3826	Subject	_
18-2	3827-3835	averaged	_
18-3	3836-3844	contrast	_
18-4	3845-3851	images	_
18-5	3852-3859	between	_
18-6	3860-3863	the	_
18-7	3864-3870	target	_
18-8	3871-3877	versus	_
18-9	3878-3881	the	_
18-10	3882-3890	standard	_
18-11	3891-3896	tones	_
18-12	3897-3901	were	_
18-13	3902-3906	used	_
18-14	3907-3909	as	_
18-15	3910-3913	the	_
18-16	3914-3921	feature	_
18-17	3922-3925	for	_
18-18	3926-3930	this	_
18-19	3931-3935	task	_
18-20	3936-3937	.	_

Text=Sternberg Item Recognition Paradigm Task This visual task required the subjects to remember a set of 1, 3, or 5 randomly chosen numbers between 0 and 9.
19-1	3938-3947	Sternberg	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-2	3948-3952	Item	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-3	3953-3964	Recognition	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-4	3965-3973	Paradigm	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-5	3974-3978	Task	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-6	3979-3983	This	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-7	3984-3990	visual	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-8	3991-3995	task	http://maven.renci.org/NeuroBridge/neurobridge#SternbergItemRecognitionParadigmTask
19-9	3996-4004	required	_
19-10	4005-4008	the	_
19-11	4009-4017	subjects	_
19-12	4018-4020	to	_
19-13	4021-4029	remember	_
19-14	4030-4031	a	_
19-15	4032-4035	set	_
19-16	4036-4038	of	_
19-17	4039-4040	1	_
19-18	4041-4042	,	_
19-19	4043-4044	3	_
19-20	4045-4046	,	_
19-21	4047-4049	or	_
19-22	4050-4051	5	_
19-23	4052-4060	randomly	_
19-24	4061-4067	chosen	_
19-25	4068-4075	numbers	_
19-26	4076-4083	between	_
19-27	4084-4085	0	_
19-28	4086-4089	and	_
19-29	4090-4091	9	_
19-30	4092-4093	.	_

Text=The task paradigm consisted of: a 1.5 second learn condition, a blank screen for 0.5 seconds, a 6 second encode condition, where the whole sequence of digits was presented together, and a 38 second probe condition, where the subject was shown a sequence of integers and had to indicate, with a right thumb button press, whether or not it was a member of the memorized set.
20-1	4094-4097	The	_
20-2	4098-4102	task	_
20-3	4103-4111	paradigm	_
20-4	4112-4121	consisted	_
20-5	4122-4124	of	_
20-6	4125-4126	:	_
20-7	4127-4128	a	_
20-8	4129-4132	1.5	_
20-9	4133-4139	second	_
20-10	4140-4145	learn	_
20-11	4146-4155	condition	_
20-12	4156-4157	,	_
20-13	4158-4159	a	_
20-14	4160-4165	blank	_
20-15	4166-4172	screen	_
20-16	4173-4176	for	_
20-17	4177-4180	0.5	_
20-18	4181-4188	seconds	_
20-19	4189-4190	,	_
20-20	4191-4192	a	_
20-21	4193-4194	6	_
20-22	4195-4201	second	_
20-23	4202-4208	encode	_
20-24	4209-4218	condition	_
20-25	4219-4220	,	_
20-26	4221-4226	where	_
20-27	4227-4230	the	_
20-28	4231-4236	whole	_
20-29	4237-4245	sequence	_
20-30	4246-4248	of	_
20-31	4249-4255	digits	_
20-32	4256-4259	was	_
20-33	4260-4269	presented	_
20-34	4270-4278	together	_
20-35	4279-4280	,	_
20-36	4281-4284	and	_
20-37	4285-4286	a	_
20-38	4287-4289	38	_
20-39	4290-4296	second	_
20-40	4297-4302	probe	_
20-41	4303-4312	condition	_
20-42	4313-4314	,	_
20-43	4315-4320	where	_
20-44	4321-4324	the	_
20-45	4325-4332	subject	_
20-46	4333-4336	was	_
20-47	4337-4342	shown	_
20-48	4343-4344	a	_
20-49	4345-4353	sequence	_
20-50	4354-4356	of	_
20-51	4357-4365	integers	_
20-52	4366-4369	and	_
20-53	4370-4373	had	_
20-54	4374-4376	to	_
20-55	4377-4385	indicate	_
20-56	4386-4387	,	_
20-57	4388-4392	with	_
20-58	4393-4394	a	_
20-59	4395-4400	right	_
20-60	4401-4406	thumb	_
20-61	4407-4413	button	_
20-62	4414-4419	press	_
20-63	4420-4421	,	_
20-64	4422-4429	whether	_
20-65	4430-4432	or	_
20-66	4433-4436	not	_
20-67	4437-4439	it	_
20-68	4440-4443	was	_
20-69	4444-4445	a	_
20-70	4446-4452	member	_
20-71	4453-4455	of	_
20-72	4456-4459	the	_
20-73	4460-4469	memorized	_
20-74	4470-4473	set	_
20-75	4474-4475	.	_

Text=Each probe digit was presented for up to 1.1 seconds in a pseudo-random fashion within a 2.7 second interval.
21-1	4476-4480	Each	_
21-2	4481-4486	probe	_
21-3	4487-4492	digit	_
21-4	4493-4496	was	_
21-5	4497-4506	presented	_
21-6	4507-4510	for	_
21-7	4511-4513	up	_
21-8	4514-4516	to	_
21-9	4517-4520	1.1	_
21-10	4521-4528	seconds	_
21-11	4529-4531	in	_
21-12	4532-4533	a	_
21-13	4534-4547	pseudo-random	_
21-14	4548-4555	fashion	_
21-15	4556-4562	within	_
21-16	4563-4564	a	_
21-17	4565-4568	2.7	_
21-18	4569-4575	second	_
21-19	4576-4584	interval	_
21-20	4585-4586	.	_

Text=A total of 84 probes, consisting of 42 targets and 42 foils was obtained per scan and the prompt-encode-probe conditions were run twice for each set size in a pseudo-random order.
22-1	4587-4588	A	_
22-2	4589-4594	total	_
22-3	4595-4597	of	_
22-4	4598-4600	84	_
22-5	4601-4607	probes	_
22-6	4608-4609	,	_
22-7	4610-4620	consisting	_
22-8	4621-4623	of	_
22-9	4624-4626	42	_
22-10	4627-4634	targets	_
22-11	4635-4638	and	_
22-12	4639-4641	42	_
22-13	4642-4647	foils	_
22-14	4648-4651	was	_
22-15	4652-4660	obtained	_
22-16	4661-4664	per	_
22-17	4665-4669	scan	_
22-18	4670-4673	and	_
22-19	4674-4677	the	_
22-20	4678-4697	prompt-encode-probe	_
22-21	4698-4708	conditions	_
22-22	4709-4713	were	_
22-23	4714-4717	run	_
22-24	4718-4723	twice	_
22-25	4724-4727	for	_
22-26	4728-4732	each	_
22-27	4733-4736	set	_
22-28	4737-4741	size	_
22-29	4742-4744	in	_
22-30	4745-4746	a	_
22-31	4747-4760	pseudo-random	_
22-32	4761-4766	order	_
22-33	4767-4768	.	_

Text=For this task, the regressor was created by convolving the probe response for the three digit set with the default SPM HRF.
23-1	4769-4772	For	_
23-2	4773-4777	this	_
23-3	4778-4782	task	_
23-4	4783-4784	,	_
23-5	4785-4788	the	_
23-6	4789-4798	regressor	_
23-7	4799-4802	was	_
23-8	4803-4810	created	_
23-9	4811-4813	by	_
23-10	4814-4824	convolving	_
23-11	4825-4828	the	_
23-12	4829-4834	probe	_
23-13	4835-4843	response	_
23-14	4844-4847	for	_
23-15	4848-4851	the	_
23-16	4852-4857	three	_
23-17	4858-4863	digit	_
23-18	4864-4867	set	_
23-19	4868-4872	with	_
23-20	4873-4876	the	_
23-21	4877-4884	default	_
23-22	4885-4888	SPM	_
23-23	4889-4892	HRF	_
23-24	4893-4894	.	_

Text=This was done for both runs of the probe response and then the average map was computed and used as the feature for this task.
24-1	4895-4899	This	_
24-2	4900-4903	was	_
24-3	4904-4908	done	_
24-4	4909-4912	for	_
24-5	4913-4917	both	_
24-6	4918-4922	runs	_
24-7	4923-4925	of	_
24-8	4926-4929	the	_
24-9	4930-4935	probe	_
24-10	4936-4944	response	_
24-11	4945-4948	and	_
24-12	4949-4953	then	_
24-13	4954-4957	the	_
24-14	4958-4965	average	_
24-15	4966-4969	map	_
24-16	4970-4973	was	_
24-17	4974-4982	computed	_
24-18	4983-4986	and	_
24-19	4987-4991	used	_
24-20	4992-4994	as	_
24-21	4995-4998	the	_
24-22	4999-5006	feature	_
24-23	5007-5010	for	_
24-24	5011-5015	this	_
24-25	5016-5020	task	_
24-26	5021-5022	.	_

Text=Sensory Motor Task This auditory task required the subjects to listen to a sequence of auditory stimuli that consisted of 16 different tones each lasting 200 ms and ranging in frequency from 236 Hz to 1,318 Hz with a 500 ms inter-stimulus interval.
25-1	5023-5030	Sensory	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-2	5031-5036	Motor	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-3	5037-5041	Task	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-4	5042-5046	This	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-5	5047-5055	auditory	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-6	5056-5060	task	http://maven.renci.org/NeuroBridge/neurobridge#SensoryMotorTask
25-7	5061-5069	required	_
25-8	5070-5073	the	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-9	5074-5082	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-10	5083-5085	to	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
25-11	5086-5092	listen	_
25-12	5093-5095	to	_
25-13	5096-5097	a	_
25-14	5098-5106	sequence	_
25-15	5107-5109	of	_
25-16	5110-5118	auditory	_
25-17	5119-5126	stimuli	_
25-18	5127-5131	that	_
25-19	5132-5141	consisted	_
25-20	5142-5144	of	_
25-21	5145-5147	16	_
25-22	5148-5157	different	_
25-23	5158-5163	tones	_
25-24	5164-5168	each	_
25-25	5169-5176	lasting	_
25-26	5177-5180	200	_
25-27	5181-5183	ms	_
25-28	5184-5187	and	_
25-29	5188-5195	ranging	_
25-30	5196-5198	in	_
25-31	5199-5208	frequency	_
25-32	5209-5213	from	_
25-33	5214-5217	236	_
25-34	5218-5220	Hz	_
25-35	5221-5223	to	_
25-36	5224-5229	1,318	_
25-37	5230-5232	Hz	_
25-38	5233-5237	with	_
25-39	5238-5239	a	_
25-40	5240-5243	500	_
25-41	5244-5246	ms	_
25-42	5247-5261	inter-stimulus	_
25-43	5262-5270	interval	_
25-44	5271-5272	.	_

Text=The first tone presented was at the lowest pitch and each subsequent tone was higher in pitch than the previous one until the highest tone was reached, then the order of the tones was reversed.
26-1	5273-5276	The	_
26-2	5277-5282	first	_
26-3	5283-5287	tone	_
26-4	5288-5297	presented	_
26-5	5298-5301	was	_
26-6	5302-5304	at	_
26-7	5305-5308	the	_
26-8	5309-5315	lowest	_
26-9	5316-5321	pitch	_
26-10	5322-5325	and	_
26-11	5326-5330	each	_
26-12	5331-5341	subsequent	_
26-13	5342-5346	tone	_
26-14	5347-5350	was	_
26-15	5351-5357	higher	_
26-16	5358-5360	in	_
26-17	5361-5366	pitch	_
26-18	5367-5371	than	_
26-19	5372-5375	the	_
26-20	5376-5384	previous	_
26-21	5385-5388	one	_
26-22	5389-5394	until	_
26-23	5395-5398	the	_
26-24	5399-5406	highest	_
26-25	5407-5411	tone	_
26-26	5412-5415	was	_
26-27	5416-5423	reached	_
26-28	5424-5425	,	_
26-29	5426-5430	then	_
26-30	5431-5434	the	_
26-31	5435-5440	order	_
26-32	5441-5443	of	_
26-33	5444-5447	the	_
26-34	5448-5453	tones	_
26-35	5454-5457	was	_
26-36	5458-5466	reversed	_
26-37	5467-5468	.	_

Text=Each tonal change required a right thumb button press.
27-1	5469-5473	Each	_
27-2	5474-5479	tonal	_
27-3	5480-5486	change	_
27-4	5487-5495	required	_
27-5	5496-5497	a	_
27-6	5498-5503	right	_
27-7	5504-5509	thumb	_
27-8	5510-5516	button	_
27-9	5517-5522	press	_
27-10	5523-5524	.	_

Text=A run consisted of 15 increase-and-decrease blocks, alternated with 15 fixation blocks, with each block lasting 16 seconds in duration.
28-1	5525-5526	A	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
28-2	5527-5530	run	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
28-3	5531-5540	consisted	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
28-4	5541-5543	of	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
28-5	5544-5546	15	http://maven.renci.org/NeuroBridge/neurobridge#BiochemicalAssay
28-6	5547-5568	increase-and-decrease	_
28-7	5569-5575	blocks	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-8	5576-5577	,	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-9	5578-5588	alternated	_
28-10	5589-5593	with	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
28-11	5594-5596	15	http://maven.renci.org/NeuroBridge/neurobridge#SubjectwithoutDisorder
28-12	5597-5605	fixation	_
28-13	5606-5612	blocks	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
28-14	5613-5614	,	_
28-15	5615-5619	with	_
28-16	5620-5624	each	_
28-17	5625-5630	block	_
28-18	5631-5638	lasting	_
28-19	5639-5641	16	_
28-20	5642-5649	seconds	_
28-21	5650-5652	in	_
28-22	5653-5661	duration	_
28-23	5662-5663	.	_

Text=For this task, the regressor was created by convolving the entire increase- and-decrease block with the default SPM HRF.
29-1	5664-5667	For	_
29-2	5668-5672	this	_
29-3	5673-5677	task	_
29-4	5678-5679	,	_
29-5	5680-5683	the	_
29-6	5684-5693	regressor	_
29-7	5694-5697	was	_
29-8	5698-5705	created	_
29-9	5706-5708	by	_
29-10	5709-5719	convolving	_
29-11	5720-5723	the	_
29-12	5724-5730	entire	_
29-13	5731-5740	increase-	_
29-14	5741-5753	and-decrease	_
29-15	5754-5759	block	_
29-16	5760-5764	with	_
29-17	5765-5768	the	_
29-18	5769-5776	default	_
29-19	5777-5780	SPM	_
29-20	5781-5784	HRF	_
29-21	5785-5786	.	_

Text=This was done for both runs for each subject and then the average map was used as the feature for this task.
30-1	5787-5791	This	_
30-2	5792-5795	was	_
30-3	5796-5800	done	_
30-4	5801-5804	for	_
30-5	5805-5809	both	_
30-6	5810-5814	runs	_
30-7	5815-5818	for	_
30-8	5819-5823	each	_
30-9	5824-5831	subject	_
30-10	5832-5835	and	_
30-11	5836-5840	then	_
30-12	5841-5844	the	_
30-13	5845-5852	average	_
30-14	5853-5856	map	_
30-15	5857-5860	was	_
30-16	5861-5865	used	_
30-17	5866-5868	as	_
30-18	5869-5872	the	_
30-19	5873-5880	feature	_
30-20	5881-5884	for	_
30-21	5885-5889	this	_
30-22	5890-5894	task	_
30-23	5895-5896	.	_

Text=ICA For an fMRI feature dataset from M subjects,, where the mth row of X is formed by flattening the feature of V voxels from the mth subject, the noiseless ICA model can be written as where the C spatially independent latent sources or neural activation patterns,, are linearly mixed by the mixing matrix,.
31-1	5897-5900	ICA	_
31-2	5901-5904	For	_
31-3	5905-5907	an	_
31-4	5908-5912	fMRI	_
31-5	5913-5920	feature	_
31-6	5921-5928	dataset	_
31-7	5929-5933	from	_
31-8	5934-5935	M	_
31-9	5936-5944	subjects	_
31-10	5945-5946	,	_
31-11	5947-5948	,	_
31-12	5949-5954	where	_
31-13	5955-5958	the	_
31-14	5959-5962	mth	_
31-15	5963-5966	row	_
31-16	5967-5969	of	_
31-17	5970-5971	X	_
31-18	5972-5974	is	_
31-19	5975-5981	formed	_
31-20	5982-5984	by	_
31-21	5985-5995	flattening	_
31-22	5996-5999	the	_
31-23	6000-6007	feature	_
31-24	6008-6010	of	_
31-25	6011-6012	V	_
31-26	6013-6019	voxels	_
31-27	6020-6024	from	_
31-28	6025-6028	the	_
31-29	6029-6032	mth	_
31-30	6033-6040	subject	_
31-31	6041-6042	,	_
31-32	6043-6046	the	_
31-33	6047-6056	noiseless	_
31-34	6057-6060	ICA	_
31-35	6061-6066	model	_
31-36	6067-6070	can	_
31-37	6071-6073	be	_
31-38	6074-6081	written	_
31-39	6082-6084	as	_
31-40	6085-6090	where	_
31-41	6091-6094	the	_
31-42	6095-6096	C	_
31-43	6097-6106	spatially	_
31-44	6107-6118	independent	_
31-45	6119-6125	latent	_
31-46	6126-6133	sources	_
31-47	6134-6136	or	_
31-48	6137-6143	neural	_
31-49	6144-6154	activation	_
31-50	6155-6163	patterns	_
31-51	6164-6165	,	_
31-52	6166-6167	,	_
31-53	6168-6171	are	_
31-54	6172-6180	linearly	_
31-55	6181-6186	mixed	_
31-56	6187-6189	by	_
31-57	6190-6193	the	_
31-58	6194-6200	mixing	_
31-59	6201-6207	matrix	_
31-60	6208-6209	,	_
31-61	6210-6211	.	_

Text=Given this model, ICA seeks to determine a demixing matrix, W, such that the estimated components, the rows of, are as independent as possible.
32-1	6212-6217	Given	_
32-2	6218-6222	this	_
32-3	6223-6228	model	_
32-4	6229-6230	,	_
32-5	6231-6234	ICA	_
32-6	6235-6240	seeks	_
32-7	6241-6243	to	_
32-8	6244-6253	determine	_
32-9	6254-6255	a	_
32-10	6256-6264	demixing	_
32-11	6265-6271	matrix	_
32-12	6272-6273	,	_
32-13	6274-6275	W	_
32-14	6276-6277	,	_
32-15	6278-6282	such	_
32-16	6283-6287	that	_
32-17	6288-6291	the	_
32-18	6292-6301	estimated	_
32-19	6302-6312	components	_
32-20	6313-6314	,	_
32-21	6315-6318	the	_
32-22	6319-6323	rows	_
32-23	6324-6326	of	_
32-24	6327-6328	,	_
32-25	6329-6332	are	_
32-26	6333-6335	as	_
32-27	6336-6347	independent	_
32-28	6348-6350	as	_
32-29	6351-6359	possible	_
32-30	6360-6361	.	_

Text=Since we seek to maximize independence between the estimated components,, estimation of the demixing matrix can be accomplished through the minimization of the mutual information among the components, written as where H (·) is the entropy.
33-1	6362-6367	Since	_
33-2	6368-6370	we	_
33-3	6371-6375	seek	_
33-4	6376-6378	to	_
33-5	6379-6387	maximize	_
33-6	6388-6400	independence	_
33-7	6401-6408	between	_
33-8	6409-6412	the	_
33-9	6413-6422	estimated	_
33-10	6423-6433	components	_
33-11	6434-6435	,	_
33-12	6436-6437	,	_
33-13	6438-6448	estimation	_
33-14	6449-6451	of	_
33-15	6452-6455	the	_
33-16	6456-6464	demixing	_
33-17	6465-6471	matrix	_
33-18	6472-6475	can	_
33-19	6476-6478	be	_
33-20	6479-6491	accomplished	_
33-21	6492-6499	through	_
33-22	6500-6503	the	_
33-23	6504-6516	minimization	_
33-24	6517-6519	of	_
33-25	6520-6523	the	_
33-26	6524-6530	mutual	_
33-27	6531-6542	information	_
33-28	6543-6548	among	_
33-29	6549-6552	the	_
33-30	6553-6563	components	_
33-31	6564-6565	,	_
33-32	6566-6573	written	_
33-33	6574-6576	as	_
33-34	6577-6582	where	_
33-35	6583-6584	H	_
33-36	6585-6586	(	_
33-37	6587-6588	·	_
33-38	6589-6590	)	_
33-39	6591-6593	is	_
33-40	6594-6597	the	_
33-41	6598-6605	entropy	_
33-42	6606-6607	.	_

Text=Since fMRI data is of high dimensionality and quite noisy, i.e., is in a space consisting of signal as well as noise, dimension-reduction using PCA is a crucial preprocessing step in order to avoid over-fitting in subsequent analyses.
34-1	6608-6613	Since	_
34-2	6614-6618	fMRI	_
34-3	6619-6623	data	_
34-4	6624-6626	is	_
34-5	6627-6629	of	_
34-6	6630-6634	high	_
34-7	6635-6649	dimensionality	_
34-8	6650-6653	and	_
34-9	6654-6659	quite	_
34-10	6660-6665	noisy	_
34-11	6666-6667	,	_
34-12	6668-6672	i.e.	_
34-13	6673-6674	,	_
34-14	6675-6677	is	_
34-15	6678-6680	in	_
34-16	6681-6682	a	_
34-17	6683-6688	space	_
34-18	6689-6699	consisting	_
34-19	6700-6702	of	_
34-20	6703-6709	signal	_
34-21	6710-6712	as	_
34-22	6713-6717	well	_
34-23	6718-6720	as	_
34-24	6721-6726	noise	_
34-25	6727-6728	,	_
34-26	6729-6748	dimension-reduction	_
34-27	6749-6754	using	_
34-28	6755-6758	PCA	_
34-29	6759-6761	is	_
34-30	6762-6763	a	_
34-31	6764-6771	crucial	_
34-32	6772-6785	preprocessing	_
34-33	6786-6790	step	_
34-34	6791-6793	in	_
34-35	6794-6799	order	_
34-36	6800-6802	to	_
34-37	6803-6808	avoid	_
34-38	6809-6821	over-fitting	_
34-39	6822-6824	in	_
34-40	6825-6835	subsequent	_
34-41	6836-6844	analyses	_
34-42	6845-6846	.	_

Text=Determining the appropriate order—the size of the signal subspace—for this PCA step using real fMRI data is an active area of research, see e.g,.
35-1	6847-6858	Determining	_
35-2	6859-6862	the	_
35-3	6863-6874	appropriate	_
35-4	6875-6884	order—the	_
35-5	6885-6889	size	_
35-6	6890-6892	of	_
35-7	6893-6896	the	_
35-8	6897-6903	signal	_
35-9	6904-6916	subspace—for	_
35-10	6917-6921	this	_
35-11	6922-6925	PCA	_
35-12	6926-6930	step	_
35-13	6931-6936	using	_
35-14	6937-6941	real	_
35-15	6942-6946	fMRI	_
35-16	6947-6951	data	_
35-17	6952-6954	is	_
35-18	6955-6957	an	_
35-19	6958-6964	active	_
35-20	6965-6969	area	_
35-21	6970-6972	of	_
35-22	6973-6981	research	_
35-23	6982-6983	,	_
35-24	6984-6987	see	_
35-25	6988-6991	e.g	_
35-26	6992-6993	,	_
35-27	6994-6995	.	_

Text=Despite its fairly extensive study, the majority of order estimation techniques are appropriate for single subject or single task analyses, which limits their applicability to the joint analysis of multiple tasks, multiset fusion.
36-1	6996-7003	Despite	_
36-2	7004-7007	its	_
36-3	7008-7014	fairly	_
36-4	7015-7024	extensive	_
36-5	7025-7030	study	_
36-6	7031-7032	,	_
36-7	7033-7036	the	_
36-8	7037-7045	majority	_
36-9	7046-7048	of	_
36-10	7049-7054	order	_
36-11	7055-7065	estimation	_
36-12	7066-7076	techniques	_
36-13	7077-7080	are	_
36-14	7081-7092	appropriate	_
36-15	7093-7096	for	_
36-16	7097-7103	single	_
36-17	7104-7111	subject	_
36-18	7112-7114	or	_
36-19	7115-7121	single	_
36-20	7122-7126	task	_
36-21	7127-7135	analyses	_
36-22	7136-7137	,	_
36-23	7138-7143	which	_
36-24	7144-7150	limits	_
36-25	7151-7156	their	_
36-26	7157-7170	applicability	_
36-27	7171-7173	to	_
36-28	7174-7177	the	_
36-29	7178-7183	joint	_
36-30	7184-7192	analysis	_
36-31	7193-7195	of	_
36-32	7196-7204	multiple	_
36-33	7205-7210	tasks	_
36-34	7211-7212	,	_
36-35	7213-7221	multiset	_
36-36	7222-7228	fusion	_
36-37	7229-7230	.	_

Text=The reason for this is that these techniques ignore the complementary information between the datasets, which is the main motivation for performing a joint analysis on such data.
37-1	7231-7234	The	_
37-2	7235-7241	reason	_
37-3	7242-7245	for	_
37-4	7246-7250	this	_
37-5	7251-7253	is	_
37-6	7254-7258	that	_
37-7	7259-7264	these	_
37-8	7265-7275	techniques	_
37-9	7276-7282	ignore	_
37-10	7283-7286	the	_
37-11	7287-7300	complementary	_
37-12	7301-7312	information	_
37-13	7313-7320	between	_
37-14	7321-7324	the	_
37-15	7325-7333	datasets	_
37-16	7334-7335	,	_
37-17	7336-7341	which	_
37-18	7342-7344	is	_
37-19	7345-7348	the	_
37-20	7349-7353	main	_
37-21	7354-7364	motivation	_
37-22	7365-7368	for	_
37-23	7369-7379	performing	_
37-24	7380-7381	a	_
37-25	7382-7387	joint	_
37-26	7388-7396	analysis	_
37-27	7397-7399	on	_
37-28	7400-7404	such	_
37-29	7405-7409	data	_
37-30	7410-7411	.	_

Text=In this work, we use the order estimated by a modification of the procedure in.
38-1	7412-7414	In	_
38-2	7415-7419	this	_
38-3	7420-7424	work	_
38-4	7425-7426	,	_
38-5	7427-7429	we	_
38-6	7430-7433	use	_
38-7	7434-7437	the	_
38-8	7438-7443	order	_
38-9	7444-7453	estimated	_
38-10	7454-7456	by	_
38-11	7457-7458	a	_
38-12	7459-7471	modification	_
38-13	7472-7474	of	_
38-14	7475-7478	the	_
38-15	7479-7488	procedure	_
38-16	7489-7491	in	_
38-17	7492-7493	.	_

Text=The reason for this is because, to the best of our knowledge, it is the only method that has shown desirable performance for the task of order estimation in both the sample-poor and sample-rich regimes inherent to the fusion of medical imaging data.
39-1	7494-7497	The	_
39-2	7498-7504	reason	_
39-3	7505-7508	for	_
39-4	7509-7513	this	_
39-5	7514-7516	is	_
39-6	7517-7524	because	_
39-7	7525-7526	,	_
39-8	7527-7529	to	_
39-9	7530-7533	the	_
39-10	7534-7538	best	_
39-11	7539-7541	of	_
39-12	7542-7545	our	_
39-13	7546-7555	knowledge	_
39-14	7556-7557	,	_
39-15	7558-7560	it	_
39-16	7561-7563	is	_
39-17	7564-7567	the	_
39-18	7568-7572	only	_
39-19	7573-7579	method	_
39-20	7580-7584	that	_
39-21	7585-7588	has	_
39-22	7589-7594	shown	_
39-23	7595-7604	desirable	_
39-24	7605-7616	performance	_
39-25	7617-7620	for	_
39-26	7621-7624	the	_
39-27	7625-7629	task	_
39-28	7630-7632	of	_
39-29	7633-7638	order	_
39-30	7639-7649	estimation	_
39-31	7650-7652	in	_
39-32	7653-7657	both	_
39-33	7658-7661	the	_
39-34	7662-7673	sample-poor	_
39-35	7674-7677	and	_
39-36	7678-7689	sample-rich	_
39-37	7690-7697	regimes	_
39-38	7698-7706	inherent	_
39-39	7707-7709	to	_
39-40	7710-7713	the	_
39-41	7714-7720	fusion	_
39-42	7721-7723	of	_
39-43	7724-7731	medical	_
39-44	7732-7739	imaging	_
39-45	7740-7744	data	_
39-46	7745-7746	.	_

Text=The technique, named PCA and canonical correlation analysis (PCA-CCA), estimates the size of the signal subspace shared by two datasets, i.e., the common order, through a sequence of binary hypothesis tests.
40-1	7747-7750	The	_
40-2	7751-7760	technique	_
40-3	7761-7762	,	_
40-4	7763-7768	named	_
40-5	7769-7772	PCA	_
40-6	7773-7776	and	_
40-7	7777-7786	canonical	_
40-8	7787-7798	correlation	_
40-9	7799-7807	analysis	_
40-10	7808-7809	(	_
40-11	7810-7817	PCA-CCA	_
40-12	7818-7819	)	_
40-13	7820-7821	,	_
40-14	7822-7831	estimates	_
40-15	7832-7835	the	_
40-16	7836-7840	size	_
40-17	7841-7843	of	_
40-18	7844-7847	the	_
40-19	7848-7854	signal	_
40-20	7855-7863	subspace	_
40-21	7864-7870	shared	_
40-22	7871-7873	by	_
40-23	7874-7877	two	_
40-24	7878-7886	datasets	_
40-25	7887-7888	,	_
40-26	7889-7893	i.e.	_
40-27	7894-7895	,	_
40-28	7896-7899	the	_
40-29	7900-7906	common	_
40-30	7907-7912	order	_
40-31	7913-7914	,	_
40-32	7915-7922	through	_
40-33	7923-7924	a	_
40-34	7925-7933	sequence	_
40-35	7934-7936	of	_
40-36	7937-7943	binary	_
40-37	7944-7954	hypothesis	_
40-38	7955-7960	tests	_
40-39	7961-7962	.	_

Text=The process begins by assuming that the common order is 0 and that the null hypothesis is that the current common order is appropriate.
41-1	7963-7966	The	_
41-2	7967-7974	process	_
41-3	7975-7981	begins	_
41-4	7982-7984	by	_
41-5	7985-7993	assuming	_
41-6	7994-7998	that	_
41-7	7999-8002	the	_
41-8	8003-8009	common	_
41-9	8010-8015	order	_
41-10	8016-8018	is	_
41-11	8019-8020	0	_
41-12	8021-8024	and	_
41-13	8025-8029	that	_
41-14	8030-8033	the	_
41-15	8034-8038	null	_
41-16	8039-8049	hypothesis	_
41-17	8050-8052	is	_
41-18	8053-8057	that	_
41-19	8058-8061	the	_
41-20	8062-8069	current	_
41-21	8070-8076	common	_
41-22	8077-8082	order	_
41-23	8083-8085	is	_
41-24	8086-8097	appropriate	_
41-25	8098-8099	.	_

Text=If the null hypothesis is rejected, the common order is increased by 1 and the test is repeated, until the null hypothesis cannot be rejected or the common dimension is equal to half the number of subjects, M/2.
42-1	8100-8102	If	_
42-2	8103-8106	the	_
42-3	8107-8111	null	_
42-4	8112-8122	hypothesis	_
42-5	8123-8125	is	_
42-6	8126-8134	rejected	_
42-7	8135-8136	,	_
42-8	8137-8140	the	_
42-9	8141-8147	common	_
42-10	8148-8153	order	_
42-11	8154-8156	is	_
42-12	8157-8166	increased	_
42-13	8167-8169	by	_
42-14	8170-8171	1	_
42-15	8172-8175	and	_
42-16	8176-8179	the	_
42-17	8180-8184	test	_
42-18	8185-8187	is	_
42-19	8188-8196	repeated	_
42-20	8197-8198	,	_
42-21	8199-8204	until	_
42-22	8205-8208	the	_
42-23	8209-8213	null	_
42-24	8214-8224	hypothesis	_
42-25	8225-8228	can	_
42-26	8229-8232	not	_
42-27	8233-8235	be	_
42-28	8236-8244	rejected	_
42-29	8245-8247	or	_
42-30	8248-8251	the	_
42-31	8252-8258	common	_
42-32	8259-8268	dimension	_
42-33	8269-8271	is	_
42-34	8272-8277	equal	_
42-35	8278-8280	to	_
42-36	8281-8285	half	_
42-37	8286-8289	the	_
42-38	8290-8296	number	_
42-39	8297-8299	of	_
42-40	8300-8308	subjects	_
42-41	8309-8310	,	_
42-42	8311-8314	M/2	_
42-43	8315-8316	.	_

Text=In this application, we estimate the order for each pairwise combination of tasks and then select the highest estimated order to enable the retention of the most complementary information across the datasets.
43-1	8317-8319	In	_
43-2	8320-8324	this	_
43-3	8325-8336	application	_
43-4	8337-8338	,	_
43-5	8339-8341	we	_
43-6	8342-8350	estimate	_
43-7	8351-8354	the	_
43-8	8355-8360	order	_
43-9	8361-8364	for	_
43-10	8365-8369	each	_
43-11	8370-8378	pairwise	_
43-12	8379-8390	combination	_
43-13	8391-8393	of	_
43-14	8394-8399	tasks	_
43-15	8400-8403	and	_
43-16	8404-8408	then	_
43-17	8409-8415	select	_
43-18	8416-8419	the	_
43-19	8420-8427	highest	_
43-20	8428-8437	estimated	_
43-21	8438-8443	order	_
43-22	8444-8446	to	_
43-23	8447-8453	enable	_
43-24	8454-8457	the	_
43-25	8458-8467	retention	_
43-26	8468-8470	of	_
43-27	8471-8474	the	_
43-28	8475-8479	most	_
43-29	8480-8493	complementary	_
43-30	8494-8505	information	_
43-31	8506-8512	across	_
43-32	8513-8516	the	_
43-33	8517-8525	datasets	_
43-34	8526-8527	.	_

Text=We should note that although there are many ICA algorithms, in this work, we used the ICA by entropy bound minimization (EBM) algorithm, due to the fact that it has shown superior performance in both simulated and real neurological data when compared with the popular Infomax algorithm, see e.g.,.
44-1	8528-8530	We	_
44-2	8531-8537	should	_
44-3	8538-8542	note	_
44-4	8543-8547	that	_
44-5	8548-8556	although	_
44-6	8557-8562	there	_
44-7	8563-8566	are	_
44-8	8567-8571	many	_
44-9	8572-8575	ICA	_
44-10	8576-8586	algorithms	_
44-11	8587-8588	,	_
44-12	8589-8591	in	_
44-13	8592-8596	this	_
44-14	8597-8601	work	_
44-15	8602-8603	,	_
44-16	8604-8606	we	_
44-17	8607-8611	used	_
44-18	8612-8615	the	_
44-19	8616-8619	ICA	_
44-20	8620-8622	by	_
44-21	8623-8630	entropy	_
44-22	8631-8636	bound	_
44-23	8637-8649	minimization	_
44-24	8650-8651	(	_
44-25	8652-8655	EBM	_
44-26	8656-8657	)	_
44-27	8658-8667	algorithm	_
44-28	8668-8669	,	_
44-29	8670-8673	due	_
44-30	8674-8676	to	_
44-31	8677-8680	the	_
44-32	8681-8685	fact	_
44-33	8686-8690	that	_
44-34	8691-8693	it	_
44-35	8694-8697	has	_
44-36	8698-8703	shown	_
44-37	8704-8712	superior	_
44-38	8713-8724	performance	_
44-39	8725-8727	in	_
44-40	8728-8732	both	_
44-41	8733-8742	simulated	_
44-42	8743-8746	and	_
44-43	8747-8751	real	_
44-44	8752-8764	neurological	_
44-45	8765-8769	data	_
44-46	8770-8774	when	_
44-47	8775-8783	compared	_
44-48	8784-8788	with	_
44-49	8789-8792	the	_
44-50	8793-8800	popular	_
44-51	8801-8808	Infomax	_
44-52	8809-8818	algorithm	_
44-53	8819-8820	,	_
44-54	8821-8824	see	_
44-55	8825-8829	e.g.	_
44-56	8830-8831	,	_
44-57	8832-8833	.	_

Text=This improved performance derives from the fact EBM does not assume a fixed form for the distribution of the latent sources and instead attempts to upper bound their entropy through the use of measuring functions.
45-1	8834-8838	This	_
45-2	8839-8847	improved	_
45-3	8848-8859	performance	_
45-4	8860-8867	derives	_
45-5	8868-8872	from	_
45-6	8873-8876	the	_
45-7	8877-8881	fact	_
45-8	8882-8885	EBM	_
45-9	8886-8890	does	_
45-10	8891-8894	not	_
45-11	8895-8901	assume	_
45-12	8902-8903	a	_
45-13	8904-8909	fixed	_
45-14	8910-8914	form	_
45-15	8915-8918	for	_
45-16	8919-8922	the	_
45-17	8923-8935	distribution	_
45-18	8936-8938	of	_
45-19	8939-8942	the	_
45-20	8943-8949	latent	_
45-21	8950-8957	sources	_
45-22	8958-8961	and	_
45-23	8962-8969	instead	_
45-24	8970-8978	attempts	_
45-25	8979-8981	to	_
45-26	8982-8987	upper	_
45-27	8988-8993	bound	_
45-28	8994-8999	their	_
45-29	9000-9007	entropy	_
45-30	9008-9015	through	_
45-31	9016-9019	the	_
45-32	9020-9023	use	_
45-33	9024-9026	of	_
45-34	9027-9036	measuring	_
45-35	9037-9046	functions	_
45-36	9047-9048	.	_

Text=The use of these measuring functions enables the description of a wide variety of distributions, including those that are: unimodal, bimodal, symmetric, and skewed, thus, generally, improving the estimation of all sources within the mixture.
46-1	9049-9052	The	_
46-2	9053-9056	use	_
46-3	9057-9059	of	_
46-4	9060-9065	these	_
46-5	9066-9075	measuring	_
46-6	9076-9085	functions	_
46-7	9086-9093	enables	_
46-8	9094-9097	the	_
46-9	9098-9109	description	_
46-10	9110-9112	of	_
46-11	9113-9114	a	_
46-12	9115-9119	wide	_
46-13	9120-9127	variety	_
46-14	9128-9130	of	_
46-15	9131-9144	distributions	_
46-16	9145-9146	,	_
46-17	9147-9156	including	_
46-18	9157-9162	those	_
46-19	9163-9167	that	_
46-20	9168-9171	are	_
46-21	9172-9173	:	_
46-22	9174-9182	unimodal	_
46-23	9183-9184	,	_
46-24	9185-9192	bimodal	_
46-25	9193-9194	,	_
46-26	9195-9204	symmetric	_
46-27	9205-9206	,	_
46-28	9207-9210	and	_
46-29	9211-9217	skewed	_
46-30	9218-9219	,	_
46-31	9220-9224	thus	_
46-32	9225-9226	,	_
46-33	9227-9236	generally	_
46-34	9237-9238	,	_
46-35	9239-9248	improving	_
46-36	9249-9252	the	_
46-37	9253-9263	estimation	_
46-38	9264-9266	of	_
46-39	9267-9270	all	_
46-40	9271-9278	sources	_
46-41	9279-9285	within	_
46-42	9286-9289	the	_
46-43	9290-9297	mixture	_
46-44	9298-9299	.	_

Text=IVA FMRI data from subjects performing multiple tasks has been increasingly gathered during the same study, since each task is expected to provide related information regarding neural function and how it is impacted by neurological diseases, such as schizophrenia, see e.g.,.
47-1	9300-9303	IVA	_
47-2	9304-9308	FMRI	_
47-3	9309-9313	data	_
47-4	9314-9318	from	_
47-5	9319-9327	subjects	_
47-6	9328-9338	performing	_
47-7	9339-9347	multiple	_
47-8	9348-9353	tasks	_
47-9	9354-9357	has	_
47-10	9358-9362	been	_
47-11	9363-9375	increasingly	_
47-12	9376-9384	gathered	_
47-13	9385-9391	during	_
47-14	9392-9395	the	_
47-15	9396-9400	same	_
47-16	9401-9406	study	_
47-17	9407-9408	,	_
47-18	9409-9414	since	_
47-19	9415-9419	each	_
47-20	9420-9424	task	_
47-21	9425-9427	is	_
47-22	9428-9436	expected	_
47-23	9437-9439	to	_
47-24	9440-9447	provide	_
47-25	9448-9455	related	_
47-26	9456-9467	information	_
47-27	9468-9477	regarding	_
47-28	9478-9484	neural	_
47-29	9485-9493	function	_
47-30	9494-9497	and	_
47-31	9498-9501	how	_
47-32	9502-9504	it	_
47-33	9505-9507	is	_
47-34	9508-9516	impacted	_
47-35	9517-9519	by	_
47-36	9520-9532	neurological	_
47-37	9533-9541	diseases	_
47-38	9542-9543	,	_
47-39	9544-9548	such	_
47-40	9549-9551	as	_
47-41	9552-9565	schizophrenia	_
47-42	9566-9567	,	_
47-43	9568-9571	see	_
47-44	9572-9576	e.g.	_
47-45	9577-9578	,	_
47-46	9579-9580	.	_

Text=In order to address this scenario, we extend the model in (1) to K datasets, or tasks, as Due to the scaling and permutation ambiguities inherent to ICA, running a separate ICA individually for each task and aligning the results is both impractical and suboptimal, since it would ignore the complementary information that each task provides.
48-1	9581-9583	In	_
48-2	9584-9589	order	_
48-3	9590-9592	to	_
48-4	9593-9600	address	_
48-5	9601-9605	this	_
48-6	9606-9614	scenario	_
48-7	9615-9616	,	_
48-8	9617-9619	we	_
48-9	9620-9626	extend	_
48-10	9627-9630	the	_
48-11	9631-9636	model	_
48-12	9637-9639	in	_
48-13	9640-9641	(	_
48-14	9642-9643	1	_
48-15	9644-9645	)	_
48-16	9646-9648	to	_
48-17	9649-9650	K	_
48-18	9651-9659	datasets	_
48-19	9660-9661	,	_
48-20	9662-9664	or	_
48-21	9665-9670	tasks	_
48-22	9671-9672	,	_
48-23	9673-9675	as	_
48-24	9676-9679	Due	_
48-25	9680-9682	to	_
48-26	9683-9686	the	_
48-27	9687-9694	scaling	_
48-28	9695-9698	and	_
48-29	9699-9710	permutation	_
48-30	9711-9722	ambiguities	_
48-31	9723-9731	inherent	_
48-32	9732-9734	to	_
48-33	9735-9738	ICA	_
48-34	9739-9740	,	_
48-35	9741-9748	running	_
48-36	9749-9750	a	_
48-37	9751-9759	separate	_
48-38	9760-9763	ICA	_
48-39	9764-9776	individually	_
48-40	9777-9780	for	_
48-41	9781-9785	each	_
48-42	9786-9790	task	_
48-43	9791-9794	and	_
48-44	9795-9803	aligning	_
48-45	9804-9807	the	_
48-46	9808-9815	results	_
48-47	9816-9818	is	_
48-48	9819-9823	both	_
48-49	9824-9835	impractical	_
48-50	9836-9839	and	_
48-51	9840-9850	suboptimal	_
48-52	9851-9852	,	_
48-53	9853-9858	since	_
48-54	9859-9861	it	_
48-55	9862-9867	would	_
48-56	9868-9874	ignore	_
48-57	9875-9878	the	_
48-58	9879-9892	complementary	_
48-59	9893-9904	information	_
48-60	9905-9909	that	_
48-61	9910-9914	each	_
48-62	9915-9919	task	_
48-63	9920-9928	provides	_
48-64	9929-9930	.	_

Text=This motivates the performance of a joint analysis, such as using IVA, a recent multiset extension of ICA, which exploits similarities across datasets to achieve a successful decomposition.
49-1	9931-9935	This	_
49-2	9936-9945	motivates	_
49-3	9946-9949	the	_
49-4	9950-9961	performance	_
49-5	9962-9964	of	_
49-6	9965-9966	a	_
49-7	9967-9972	joint	_
49-8	9973-9981	analysis	_
49-9	9982-9983	,	_
49-10	9984-9988	such	_
49-11	9989-9991	as	_
49-12	9992-9997	using	_
49-13	9998-10001	IVA	_
49-14	10002-10003	,	_
49-15	10004-10005	a	_
49-16	10006-10012	recent	_
49-17	10013-10021	multiset	_
49-18	10022-10031	extension	_
49-19	10032-10034	of	_
49-20	10035-10038	ICA	_
49-21	10039-10040	,	_
49-22	10041-10046	which	_
49-23	10047-10055	exploits	_
49-24	10056-10068	similarities	_
49-25	10069-10075	across	_
49-26	10076-10084	datasets	_
49-27	10085-10087	to	_
49-28	10088-10095	achieve	_
49-29	10096-10097	a	_
49-30	10098-10108	successful	_
49-31	10109-10122	decomposition	_
49-32	10123-10124	.	_

Text=The mutual information cost function for IVA can be written as, where is the cth source component matrix (SCM), formed by concatenating the cth estimated component from each of the datasets.
50-1	10125-10128	The	_
50-2	10129-10135	mutual	_
50-3	10136-10147	information	_
50-4	10148-10152	cost	_
50-5	10153-10161	function	_
50-6	10162-10165	for	_
50-7	10166-10169	IVA	_
50-8	10170-10173	can	_
50-9	10174-10176	be	_
50-10	10177-10184	written	_
50-11	10185-10187	as	_
50-12	10188-10189	,	_
50-13	10190-10195	where	_
50-14	10196-10198	is	_
50-15	10199-10202	the	_
50-16	10203-10206	cth	_
50-17	10207-10213	source	_
50-18	10214-10223	component	_
50-19	10224-10230	matrix	_
50-20	10231-10232	(	_
50-21	10233-10236	SCM	_
50-22	10237-10238	)	_
50-23	10239-10240	,	_
50-24	10241-10247	formed	_
50-25	10248-10250	by	_
50-26	10251-10264	concatenating	_
50-27	10265-10268	the	_
50-28	10269-10272	cth	_
50-29	10273-10282	estimated	_
50-30	10283-10292	component	_
50-31	10293-10297	from	_
50-32	10298-10302	each	_
50-33	10303-10305	of	_
50-34	10306-10309	the	_
50-35	10310-10318	datasets	_
50-36	10319-10320	.	_

Text=Note that the difference between (2) and (4) is that we are now minimizing the mutual information between SCMs and not components.
51-1	10321-10325	Note	_
51-2	10326-10330	that	_
51-3	10331-10334	the	_
51-4	10335-10345	difference	_
51-5	10346-10353	between	_
51-6	10354-10355	(	_
51-7	10356-10357	2	_
51-8	10358-10359	)	_
51-9	10360-10363	and	_
51-10	10364-10365	(	_
51-11	10366-10367	4	_
51-12	10368-10369	)	_
51-13	10370-10372	is	_
51-14	10373-10377	that	_
51-15	10378-10380	we	_
51-16	10381-10384	are	_
51-17	10385-10388	now	_
51-18	10389-10399	minimizing	_
51-19	10400-10403	the	_
51-20	10404-10410	mutual	_
51-21	10411-10422	information	_
51-22	10423-10430	between	_
51-23	10431-10435	SCMs	_
51-24	10436-10439	and	_
51-25	10440-10443	not	_
51-26	10444-10454	components	_
51-27	10455-10456	.	_

Text=This cost function reduces to the sum of separate ICAs performed on each dataset individually if the sources in each of the datasets are mutually independent of each other.
52-1	10457-10461	This	_
52-2	10462-10466	cost	_
52-3	10467-10475	function	_
52-4	10476-10483	reduces	_
52-5	10484-10486	to	_
52-6	10487-10490	the	_
52-7	10491-10494	sum	_
52-8	10495-10497	of	_
52-9	10498-10506	separate	_
52-10	10507-10511	ICAs	_
52-11	10512-10521	performed	_
52-12	10522-10524	on	_
52-13	10525-10529	each	_
52-14	10530-10537	dataset	_
52-15	10538-10550	individually	_
52-16	10551-10553	if	_
52-17	10554-10557	the	_
52-18	10558-10565	sources	_
52-19	10566-10568	in	_
52-20	10569-10573	each	_
52-21	10574-10576	of	_
52-22	10577-10580	the	_
52-23	10581-10589	datasets	_
52-24	10590-10593	are	_
52-25	10594-10602	mutually	_
52-26	10603-10614	independent	_
52-27	10615-10617	of	_
52-28	10618-10622	each	_
52-29	10623-10628	other	_
52-30	10629-10630	.	_

Text=In this work, IVA via a multivariate Gaussian and Laplacian algorithm is used, since it has proven to be an effective IVA algorithm for analysis of fMRI data, see e.g.,.
53-1	10631-10633	In	_
53-2	10634-10638	this	_
53-3	10639-10643	work	_
53-4	10644-10645	,	_
53-5	10646-10649	IVA	_
53-6	10650-10653	via	_
53-7	10654-10655	a	_
53-8	10656-10668	multivariate	_
53-9	10669-10677	Gaussian	_
53-10	10678-10681	and	_
53-11	10682-10691	Laplacian	_
53-12	10692-10701	algorithm	_
53-13	10702-10704	is	_
53-14	10705-10709	used	_
53-15	10710-10711	,	_
53-16	10712-10717	since	_
53-17	10718-10720	it	_
53-18	10721-10724	has	_
53-19	10725-10731	proven	_
53-20	10732-10734	to	_
53-21	10735-10737	be	_
53-22	10738-10740	an	_
53-23	10741-10750	effective	_
53-24	10751-10754	IVA	_
53-25	10755-10764	algorithm	_
53-26	10765-10768	for	_
53-27	10769-10777	analysis	_
53-28	10778-10780	of	_
53-29	10781-10785	fMRI	_
53-30	10786-10790	data	_
53-31	10791-10792	,	_
53-32	10793-10796	see	_
53-33	10797-10801	e.g.	_
53-34	10802-10803	,	_
53-35	10804-10805	.	_

Text=GDMs As discussed in Section 2.3, since the data from each subject within a task has been reduced to a feature, the columns of the estimated mixing matrix, A, provide the weight of each component across the subjects.
54-1	10806-10810	GDMs	_
54-2	10811-10813	As	_
54-3	10814-10823	discussed	_
54-4	10824-10826	in	_
54-5	10827-10834	Section	_
54-6	10835-10838	2.3	_
54-7	10839-10840	,	_
54-8	10841-10846	since	_
54-9	10847-10850	the	_
54-10	10851-10855	data	_
54-11	10856-10860	from	_
54-12	10861-10865	each	_
54-13	10866-10873	subject	_
54-14	10874-10880	within	_
54-15	10881-10882	a	_
54-16	10883-10887	task	_
54-17	10888-10891	has	_
54-18	10892-10896	been	_
54-19	10897-10904	reduced	_
54-20	10905-10907	to	_
54-21	10908-10909	a	_
54-22	10910-10917	feature	_
54-23	10918-10919	,	_
54-24	10920-10923	the	_
54-25	10924-10931	columns	_
54-26	10932-10934	of	_
54-27	10935-10938	the	_
54-28	10939-10948	estimated	_
54-29	10949-10955	mixing	_
54-30	10956-10962	matrix	_
54-31	10963-10964	,	_
54-32	10965-10966	A	_
54-33	10967-10968	,	_
54-34	10969-10976	provide	_
54-35	10977-10980	the	_
54-36	10981-10987	weight	_
54-37	10988-10990	of	_
54-38	10991-10995	each	_
54-39	10996-11005	component	_
54-40	11006-11012	across	_
54-41	11013-11016	the	_
54-42	11017-11025	subjects	_
54-43	11026-11027	.	_

Text=This means that the ith column of the estimated mixing matrix, ai, represents the subject-specific weights of the ith source estimate, si.
55-1	11028-11032	This	_
55-2	11033-11038	means	_
55-3	11039-11043	that	_
55-4	11044-11047	the	_
55-5	11048-11051	ith	_
55-6	11052-11058	column	_
55-7	11059-11061	of	_
55-8	11062-11065	the	_
55-9	11066-11075	estimated	_
55-10	11076-11082	mixing	_
55-11	11083-11089	matrix	_
55-12	11090-11091	,	_
55-13	11092-11094	ai	_
55-14	11095-11096	,	_
55-15	11097-11107	represents	_
55-16	11108-11111	the	_
55-17	11112-11128	subject-specific	_
55-18	11129-11136	weights	_
55-19	11137-11139	of	_
55-20	11140-11143	the	_
55-21	11144-11147	ith	_
55-22	11148-11154	source	_
55-23	11155-11163	estimate	_
55-24	11164-11165	,	_
55-25	11166-11168	si	_
55-26	11169-11170	.	_

Text=Thus, if the goal of the study is to determine a set of explanatory factors that can be used to assess differences between two groups, as is the primary focus for this work where the groups are patients with schizophrenia and healthy controls, the weights can be used to determine if any component is expressed differently across the two groups.
56-1	11171-11175	Thus	_
56-2	11176-11177	,	_
56-3	11178-11180	if	_
56-4	11181-11184	the	_
56-5	11185-11189	goal	_
56-6	11190-11192	of	_
56-7	11193-11196	the	_
56-8	11197-11202	study	_
56-9	11203-11205	is	_
56-10	11206-11208	to	_
56-11	11209-11218	determine	_
56-12	11219-11220	a	_
56-13	11221-11224	set	_
56-14	11225-11227	of	_
56-15	11228-11239	explanatory	_
56-16	11240-11247	factors	_
56-17	11248-11252	that	_
56-18	11253-11256	can	_
56-19	11257-11259	be	_
56-20	11260-11264	used	_
56-21	11265-11267	to	_
56-22	11268-11274	assess	_
56-23	11275-11286	differences	_
56-24	11287-11294	between	_
56-25	11295-11298	two	_
56-26	11299-11305	groups	_
56-27	11306-11307	,	_
56-28	11308-11310	as	_
56-29	11311-11313	is	_
56-30	11314-11317	the	_
56-31	11318-11325	primary	_
56-32	11326-11331	focus	_
56-33	11332-11335	for	_
56-34	11336-11340	this	_
56-35	11341-11345	work	_
56-36	11346-11351	where	_
56-37	11352-11355	the	_
56-38	11356-11362	groups	_
56-39	11363-11366	are	_
56-40	11367-11375	patients	_
56-41	11376-11380	with	_
56-42	11381-11394	schizophrenia	_
56-43	11395-11398	and	_
56-44	11399-11406	healthy	_
56-45	11407-11415	controls	_
56-46	11416-11417	,	_
56-47	11418-11421	the	_
56-48	11422-11429	weights	_
56-49	11430-11433	can	_
56-50	11434-11436	be	_
56-51	11437-11441	used	_
56-52	11442-11444	to	_
56-53	11445-11454	determine	_
56-54	11455-11457	if	_
56-55	11458-11461	any	_
56-56	11462-11471	component	_
56-57	11472-11474	is	_
56-58	11475-11484	expressed	_
56-59	11485-11496	differently	_
56-60	11497-11503	across	_
56-61	11504-11507	the	_
56-62	11508-11511	two	_
56-63	11512-11518	groups	_
56-64	11519-11520	.	_

Text=In order to statistically determine components that have different expressions, on average, between patients and controls, a two-sample t-test is performed on columns of A, where one group is represented by the weights corresponding to the patients with schizophrenia and the other by the weights corresponding to the healthy controls.
57-1	11521-11523	In	_
57-2	11524-11529	order	_
57-3	11530-11532	to	_
57-4	11533-11546	statistically	_
57-5	11547-11556	determine	_
57-6	11557-11567	components	_
57-7	11568-11572	that	_
57-8	11573-11577	have	_
57-9	11578-11587	different	_
57-10	11588-11599	expressions	_
57-11	11600-11601	,	_
57-12	11602-11604	on	_
57-13	11605-11612	average	_
57-14	11613-11614	,	_
57-15	11615-11622	between	_
57-16	11623-11631	patients	_
57-17	11632-11635	and	_
57-18	11636-11644	controls	_
57-19	11645-11646	,	_
57-20	11647-11648	a	_
57-21	11649-11659	two-sample	_
57-22	11660-11666	t-test	_
57-23	11667-11669	is	_
57-24	11670-11679	performed	_
57-25	11680-11682	on	_
57-26	11683-11690	columns	_
57-27	11691-11693	of	_
57-28	11694-11695	A	_
57-29	11696-11697	,	_
57-30	11698-11703	where	_
57-31	11704-11707	one	_
57-32	11708-11713	group	_
57-33	11714-11716	is	_
57-34	11717-11728	represented	_
57-35	11729-11731	by	_
57-36	11732-11735	the	_
57-37	11736-11743	weights	_
57-38	11744-11757	corresponding	_
57-39	11758-11760	to	_
57-40	11761-11764	the	_
57-41	11765-11773	patients	_
57-42	11774-11778	with	_
57-43	11779-11792	schizophrenia	_
57-44	11793-11796	and	_
57-45	11797-11800	the	_
57-46	11801-11806	other	_
57-47	11807-11809	by	_
57-48	11810-11813	the	_
57-49	11814-11821	weights	_
57-50	11822-11835	corresponding	_
57-51	11836-11838	to	_
57-52	11839-11842	the	_
57-53	11843-11850	healthy	_
57-54	11851-11859	controls	_
57-55	11860-11861	.	_

Text=The formula for the two-sample t-test is presented below where μi,, ni are the mean, variance, and number of samples in group i.
58-1	11862-11865	The	_
58-2	11866-11873	formula	_
58-3	11874-11877	for	_
58-4	11878-11881	the	_
58-5	11882-11892	two-sample	_
58-6	11893-11899	t-test	_
58-7	11900-11902	is	_
58-8	11903-11912	presented	_
58-9	11913-11918	below	_
58-10	11919-11924	where	_
58-11	11925-11927	μi	_
58-12	11928-11929	,	_
58-13	11930-11931	,	_
58-14	11932-11934	ni	_
58-15	11935-11938	are	_
58-16	11939-11942	the	_
58-17	11943-11947	mean	_
58-18	11948-11949	,	_
58-19	11950-11958	variance	_
58-20	11959-11960	,	_
58-21	11961-11964	and	_
58-22	11965-11971	number	_
58-23	11972-11974	of	_
58-24	11975-11982	samples	_
58-25	11983-11985	in	_
58-26	11986-11991	group	_
58-27	11992-11993	i	_
58-28	11994-11995	.	_

Text=Note that when the difference between the weights of the two groups is statistically significant, the component describes functional differences between patients and controls and is referred to as a possible biomarker of disease.
59-1	11996-12000	Note	_
59-2	12001-12005	that	_
59-3	12006-12010	when	_
59-4	12011-12014	the	_
59-5	12015-12025	difference	_
59-6	12026-12033	between	_
59-7	12034-12037	the	_
59-8	12038-12045	weights	_
59-9	12046-12048	of	_
59-10	12049-12052	the	_
59-11	12053-12056	two	_
59-12	12057-12063	groups	_
59-13	12064-12066	is	_
59-14	12067-12080	statistically	_
59-15	12081-12092	significant	_
59-16	12093-12094	,	_
59-17	12095-12098	the	_
59-18	12099-12108	component	_
59-19	12109-12118	describes	_
59-20	12119-12129	functional	_
59-21	12130-12141	differences	_
59-22	12142-12149	between	_
59-23	12150-12158	patients	_
59-24	12159-12162	and	_
59-25	12163-12171	controls	_
59-26	12172-12175	and	_
59-27	12176-12178	is	_
59-28	12179-12187	referred	_
59-29	12188-12190	to	_
59-30	12191-12193	as	_
59-31	12194-12195	a	_
59-32	12196-12204	possible	_
59-33	12205-12214	biomarker	_
59-34	12215-12217	of	_
59-35	12218-12225	disease	_
59-36	12226-12227	.	_

Text=The t-statistics derived from these tests can serve as the basis for the construction of the GDMs.
60-1	12228-12231	The	_
60-2	12232-12244	t-statistics	_
60-3	12245-12252	derived	_
60-4	12253-12257	from	_
60-5	12258-12263	these	_
60-6	12264-12269	tests	_
60-7	12270-12273	can	_
60-8	12274-12279	serve	_
60-9	12280-12282	as	_
60-10	12283-12286	the	_
60-11	12287-12292	basis	_
60-12	12293-12296	for	_
60-13	12297-12300	the	_
60-14	12301-12313	construction	_
60-15	12314-12316	of	_
60-16	12317-12320	the	_
60-17	12321-12325	GDMs	_
60-18	12326-12327	.	_

Text=Before describing how we construct GDMs, we should note that, since an important focus of this study is differentiating patients with schizophrenia from healthy controls, we focus on how GDMs can highlight the brain regions that differentiate between two groups.
61-1	12328-12334	Before	_
61-2	12335-12345	describing	_
61-3	12346-12349	how	_
61-4	12350-12352	we	_
61-5	12353-12362	construct	_
61-6	12363-12367	GDMs	_
61-7	12368-12369	,	_
61-8	12370-12372	we	_
61-9	12373-12379	should	_
61-10	12380-12384	note	_
61-11	12385-12389	that	_
61-12	12390-12391	,	_
61-13	12392-12397	since	_
61-14	12398-12400	an	_
61-15	12401-12410	important	_
61-16	12411-12416	focus	_
61-17	12417-12419	of	_
61-18	12420-12424	this	_
61-19	12425-12430	study	_
61-20	12431-12433	is	_
61-21	12434-12449	differentiating	_
61-22	12450-12458	patients	_
61-23	12459-12463	with	_
61-24	12464-12477	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
61-25	12478-12482	from	_
61-26	12483-12490	healthy	_
61-27	12491-12499	controls	_
61-28	12500-12501	,	_
61-29	12502-12504	we	_
61-30	12505-12510	focus	_
61-31	12511-12513	on	_
61-32	12514-12517	how	_
61-33	12518-12522	GDMs	_
61-34	12523-12526	can	_
61-35	12527-12536	highlight	_
61-36	12537-12540	the	_
61-37	12541-12546	brain	_
61-38	12547-12554	regions	_
61-39	12555-12559	that	_
61-40	12560-12573	differentiate	_
61-41	12574-12581	between	_
61-42	12582-12585	two	_
61-43	12586-12592	groups	_
61-44	12593-12594	.	_

Text=However, as we describe at the end of this section, GDMs can also be constructed such that they reflect the regions that are correlated with certain behavioral variables of interest, highlighting associations between psychological tests and neural function.
62-1	12595-12602	However	_
62-2	12603-12604	,	_
62-3	12605-12607	as	_
62-4	12608-12610	we	_
62-5	12611-12619	describe	_
62-6	12620-12622	at	_
62-7	12623-12626	the	_
62-8	12627-12630	end	_
62-9	12631-12633	of	_
62-10	12634-12638	this	_
62-11	12639-12646	section	_
62-12	12647-12648	,	_
62-13	12649-12653	GDMs	_
62-14	12654-12657	can	_
62-15	12658-12662	also	_
62-16	12663-12665	be	_
62-17	12666-12677	constructed	_
62-18	12678-12682	such	_
62-19	12683-12687	that	_
62-20	12688-12692	they	_
62-21	12693-12700	reflect	_
62-22	12701-12704	the	_
62-23	12705-12712	regions	_
62-24	12713-12717	that	_
62-25	12718-12721	are	_
62-26	12722-12732	correlated	_
62-27	12733-12737	with	_
62-28	12738-12745	certain	_
62-29	12746-12756	behavioral	_
62-30	12757-12766	variables	_
62-31	12767-12769	of	_
62-32	12770-12778	interest	_
62-33	12779-12780	,	_
62-34	12781-12793	highlighting	_
62-35	12794-12806	associations	_
62-36	12807-12814	between	_
62-37	12815-12828	psychological	_
62-38	12829-12834	tests	_
62-39	12835-12838	and	_
62-40	12839-12845	neural	_
62-41	12846-12854	function	_
62-42	12855-12856	.	_

Text=Due to the scaling ambiguity of ICA, prior to the construction of GDMs, Z-scores are independently computed from the individual biomarkers using the mean and standard deviation computed using all voxels.
63-1	12857-12860	Due	_
63-2	12861-12863	to	_
63-3	12864-12867	the	_
63-4	12868-12875	scaling	_
63-5	12876-12885	ambiguity	_
63-6	12886-12888	of	_
63-7	12889-12892	ICA	_
63-8	12893-12894	,	_
63-9	12895-12900	prior	_
63-10	12901-12903	to	_
63-11	12904-12907	the	_
63-12	12908-12920	construction	_
63-13	12921-12923	of	_
63-14	12924-12928	GDMs	_
63-15	12929-12930	,	_
63-16	12931-12939	Z-scores	_
63-17	12940-12943	are	_
63-18	12944-12957	independently	_
63-19	12958-12966	computed	_
63-20	12967-12971	from	_
63-21	12972-12975	the	_
63-22	12976-12986	individual	_
63-23	12987-12997	biomarkers	_
63-24	12998-13003	using	_
63-25	13004-13007	the	_
63-26	13008-13012	mean	_
63-27	13013-13016	and	_
63-28	13017-13025	standard	_
63-29	13026-13035	deviation	_
63-30	13036-13044	computed	_
63-31	13045-13050	using	_
63-32	13051-13054	all	_
63-33	13055-13061	voxels	_
63-34	13062-13063	.	_

Text=Let N be subset of the C components estimated using separate ICAs or IVA for each dataset with weights that are statistically significantly different, at p <0.05, between patients and controls.
64-1	13064-13067	Let	_
64-2	13068-13069	N	_
64-3	13070-13072	be	_
64-4	13073-13079	subset	_
64-5	13080-13082	of	_
64-6	13083-13086	the	_
64-7	13087-13088	C	_
64-8	13089-13099	components	_
64-9	13100-13109	estimated	_
64-10	13110-13115	using	_
64-11	13116-13124	separate	_
64-12	13125-13129	ICAs	_
64-13	13130-13132	or	_
64-14	13133-13136	IVA	_
64-15	13137-13140	for	_
64-16	13141-13145	each	_
64-17	13146-13153	dataset	_
64-18	13154-13158	with	_
64-19	13159-13166	weights	_
64-20	13167-13171	that	_
64-21	13172-13175	are	_
64-22	13176-13189	statistically	_
64-23	13190-13203	significantly	_
64-24	13204-13213	different	_
64-25	13214-13215	,	_
64-26	13216-13218	at	_
64-27	13219-13220	p	_
64-28	13221-13222	<	_
64-29	13223-13227	0.05	_
64-30	13228-13229	,	_
64-31	13230-13237	between	_
64-32	13238-13246	patients	_
64-33	13247-13250	and	_
64-34	13251-13259	controls	_
64-35	13260-13261	.	_

Text=Denoting these components as, we construct the GDM for that method and dataset,, as follows where tn is the t-statistic, calculated as described in Section 2.3, for the nth component that is positive or made to be positive by multiplying the corresponding subject covariation and component by −1.
65-1	13262-13270	Denoting	_
65-2	13271-13276	these	_
65-3	13277-13287	components	_
65-4	13288-13290	as	_
65-5	13291-13292	,	_
65-6	13293-13295	we	_
65-7	13296-13305	construct	_
65-8	13306-13309	the	_
65-9	13310-13313	GDM	_
65-10	13314-13317	for	_
65-11	13318-13322	that	_
65-12	13323-13329	method	_
65-13	13330-13333	and	_
65-14	13334-13341	dataset	_
65-15	13342-13343	,	_
65-16	13344-13345	,	_
65-17	13346-13348	as	_
65-18	13349-13356	follows	_
65-19	13357-13362	where	_
65-20	13363-13365	tn	_
65-21	13366-13368	is	_
65-22	13369-13372	the	_
65-23	13373-13384	t-statistic	_
65-24	13385-13386	,	_
65-25	13387-13397	calculated	_
65-26	13398-13400	as	_
65-27	13401-13410	described	_
65-28	13411-13413	in	_
65-29	13414-13421	Section	_
65-30	13422-13425	2.3	_
65-31	13426-13427	,	_
65-32	13428-13431	for	_
65-33	13432-13435	the	_
65-34	13436-13439	nth	_
65-35	13440-13449	component	_
65-36	13450-13454	that	_
65-37	13455-13457	is	_
65-38	13458-13466	positive	_
65-39	13467-13469	or	_
65-40	13470-13474	made	_
65-41	13475-13477	to	_
65-42	13478-13480	be	_
65-43	13481-13489	positive	_
65-44	13490-13492	by	_
65-45	13493-13504	multiplying	_
65-46	13505-13508	the	_
65-47	13509-13522	corresponding	_
65-48	13523-13530	subject	_
65-49	13531-13542	covariation	_
65-50	13543-13546	and	_
65-51	13547-13556	component	_
65-52	13557-13559	by	_
65-53	13560-13562	−1	_
65-54	13563-13564	.	_

Text=Note that due to the sign ambiguity associated with ICA and IVA, multiplying both the component as well as the subject covariation by −1 will produce the same solution.
66-1	13565-13569	Note	_
66-2	13570-13574	that	_
66-3	13575-13578	due	_
66-4	13579-13581	to	_
66-5	13582-13585	the	_
66-6	13586-13590	sign	_
66-7	13591-13600	ambiguity	_
66-8	13601-13611	associated	_
66-9	13612-13616	with	_
66-10	13617-13620	ICA	_
66-11	13621-13624	and	_
66-12	13625-13628	IVA	_
66-13	13629-13630	,	_
66-14	13631-13642	multiplying	_
66-15	13643-13647	both	_
66-16	13648-13651	the	_
66-17	13652-13661	component	_
66-18	13662-13664	as	_
66-19	13665-13669	well	_
66-20	13670-13672	as	_
66-21	13673-13676	the	_
66-22	13677-13684	subject	_
66-23	13685-13696	covariation	_
66-24	13697-13699	by	_
66-25	13700-13702	−1	_
66-26	13703-13707	will	_
66-27	13708-13715	produce	_
66-28	13716-13719	the	_
66-29	13720-13724	same	_
66-30	13725-13733	solution	_
66-31	13734-13735	.	_

Text=The physical interpretation of such a transformation is that, for example, rather than having patients have increased activation in a certain region over controls, controls have increased deactivation over patients.
67-1	13736-13739	The	_
67-2	13740-13748	physical	_
67-3	13749-13763	interpretation	_
67-4	13764-13766	of	_
67-5	13767-13771	such	_
67-6	13772-13773	a	_
67-7	13774-13788	transformation	_
67-8	13789-13791	is	_
67-9	13792-13796	that	_
67-10	13797-13798	,	_
67-11	13799-13802	for	_
67-12	13803-13810	example	_
67-13	13811-13812	,	_
67-14	13813-13819	rather	_
67-15	13820-13824	than	_
67-16	13825-13831	having	_
67-17	13832-13840	patients	_
67-18	13841-13845	have	_
67-19	13846-13855	increased	_
67-20	13856-13866	activation	_
67-21	13867-13869	in	_
67-22	13870-13871	a	_
67-23	13872-13879	certain	_
67-24	13880-13886	region	_
67-25	13887-13891	over	_
67-26	13892-13900	controls	_
67-27	13901-13902	,	_
67-28	13903-13911	controls	_
67-29	13912-13916	have	_
67-30	13917-13926	increased	_
67-31	13927-13939	deactivation	_
67-32	13940-13944	over	_
67-33	13945-13953	patients	_
67-34	13954-13955	.	_

Text=The GDM can be seen as a summary map that describes only the regions that activate/deactivate significantly differently between patients and controls for a given decomposition and dataset within that decomposition.
68-1	13956-13959	The	_
68-2	13960-13963	GDM	_
68-3	13964-13967	can	_
68-4	13968-13970	be	_
68-5	13971-13975	seen	_
68-6	13976-13978	as	_
68-7	13979-13980	a	_
68-8	13981-13988	summary	_
68-9	13989-13992	map	_
68-10	13993-13997	that	_
68-11	13998-14007	describes	_
68-12	14008-14012	only	_
68-13	14013-14016	the	_
68-14	14017-14024	regions	_
68-15	14025-14029	that	_
68-16	14030-14049	activate/deactivate	_
68-17	14050-14063	significantly	_
68-18	14064-14075	differently	_
68-19	14076-14083	between	_
68-20	14084-14092	patients	_
68-21	14093-14096	and	_
68-22	14097-14105	controls	_
68-23	14106-14109	for	_
68-24	14110-14111	a	_
68-25	14112-14117	given	_
68-26	14118-14131	decomposition	_
68-27	14132-14135	and	_
68-28	14136-14143	dataset	_
68-29	14144-14150	within	_
68-30	14151-14155	that	_
68-31	14156-14169	decomposition	_
68-32	14170-14171	.	_

Text=Each biomarker is scaled by the value of its corresponding t-statistic, so has more weight if the component is better able to differentiate between patients and controls.
69-1	14172-14176	Each	_
69-2	14177-14186	biomarker	_
69-3	14187-14189	is	_
69-4	14190-14196	scaled	_
69-5	14197-14199	by	_
69-6	14200-14203	the	_
69-7	14204-14209	value	_
69-8	14210-14212	of	_
69-9	14213-14216	its	_
69-10	14217-14230	corresponding	_
69-11	14231-14242	t-statistic	_
69-12	14243-14244	,	_
69-13	14245-14247	so	_
69-14	14248-14251	has	_
69-15	14252-14256	more	_
69-16	14257-14263	weight	_
69-17	14264-14266	if	_
69-18	14267-14270	the	_
69-19	14271-14280	component	_
69-20	14281-14283	is	_
69-21	14284-14290	better	_
69-22	14291-14295	able	_
69-23	14296-14298	to	_
69-24	14299-14312	differentiate	_
69-25	14313-14320	between	_
69-26	14321-14329	patients	_
69-27	14330-14333	and	_
69-28	14334-14342	controls	_
69-29	14343-14344	.	_

Text=Note that though we describe the construction of GDMs for factors extracted using ICA and IVA, they could also be constructed using the results of any factor analysis, such as PCA, NMF, or DL.
70-1	14345-14349	Note	_
70-2	14350-14354	that	_
70-3	14355-14361	though	_
70-4	14362-14364	we	_
70-5	14365-14373	describe	_
70-6	14374-14377	the	_
70-7	14378-14390	construction	_
70-8	14391-14393	of	_
70-9	14394-14398	GDMs	_
70-10	14399-14402	for	_
70-11	14403-14410	factors	_
70-12	14411-14420	extracted	_
70-13	14421-14426	using	_
70-14	14427-14430	ICA	_
70-15	14431-14434	and	_
70-16	14435-14438	IVA	_
70-17	14439-14440	,	_
70-18	14441-14445	they	_
70-19	14446-14451	could	_
70-20	14452-14456	also	_
70-21	14457-14459	be	_
70-22	14460-14471	constructed	_
70-23	14472-14477	using	_
70-24	14478-14481	the	_
70-25	14482-14489	results	_
70-26	14490-14492	of	_
70-27	14493-14496	any	_
70-28	14497-14503	factor	_
70-29	14504-14512	analysis	_
70-30	14513-14514	,	_
70-31	14515-14519	such	_
70-32	14520-14522	as	_
70-33	14523-14526	PCA	_
70-34	14527-14528	,	_
70-35	14529-14532	NMF	_
70-36	14533-14534	,	_
70-37	14535-14537	or	_
70-38	14538-14540	DL	_
70-39	14541-14542	.	_

Text=Additionally, though beyond the scope of this work, GDMs can also be defined based upon regression models, which are useful when there are less clearly defined groups.
71-1	14543-14555	Additionally	_
71-2	14556-14557	,	_
71-3	14558-14564	though	_
71-4	14565-14571	beyond	_
71-5	14572-14575	the	_
71-6	14576-14581	scope	_
71-7	14582-14584	of	_
71-8	14585-14589	this	_
71-9	14590-14594	work	_
71-10	14595-14596	,	_
71-11	14597-14601	GDMs	_
71-12	14602-14605	can	_
71-13	14606-14610	also	_
71-14	14611-14613	be	_
71-15	14614-14621	defined	_
71-16	14622-14627	based	_
71-17	14628-14632	upon	_
71-18	14633-14643	regression	_
71-19	14644-14650	models	_
71-20	14651-14652	,	_
71-21	14653-14658	which	_
71-22	14659-14662	are	_
71-23	14663-14669	useful	_
71-24	14670-14674	when	_
71-25	14675-14680	there	_
71-26	14681-14684	are	_
71-27	14685-14689	less	_
71-28	14690-14697	clearly	_
71-29	14698-14705	defined	_
71-30	14706-14712	groups	_
71-31	14713-14714	.	_

Text=Though we should note that using general linear models where the regressor is the disease state of the subjects is, generally, less robust than factor models in this case.
72-1	14715-14721	Though	_
72-2	14722-14724	we	_
72-3	14725-14731	should	_
72-4	14732-14736	note	_
72-5	14737-14741	that	_
72-6	14742-14747	using	_
72-7	14748-14755	general	_
72-8	14756-14762	linear	_
72-9	14763-14769	models	_
72-10	14770-14775	where	_
72-11	14776-14779	the	_
72-12	14780-14789	regressor	_
72-13	14790-14792	is	_
72-14	14793-14796	the	_
72-15	14797-14804	disease	_
72-16	14805-14810	state	_
72-17	14811-14813	of	_
72-18	14814-14817	the	_
72-19	14818-14826	subjects	_
72-20	14827-14829	is	_
72-21	14830-14831	,	_
72-22	14832-14841	generally	_
72-23	14842-14843	,	_
72-24	14844-14848	less	_
72-25	14849-14855	robust	_
72-26	14856-14860	than	_
72-27	14861-14867	factor	_
72-28	14868-14874	models	_
72-29	14875-14877	in	_
72-30	14878-14882	this	_
72-31	14883-14887	case	_
72-32	14888-14889	.	_

Text=We can quantify the discriminative power of a GDM, and thus, indirectly, the whole decomposition, by generating component weights in a nearly identical manner to the GDM spatial maps and performing a two-sample t-test on the resulting weights.
73-1	14890-14892	We	_
73-2	14893-14896	can	_
73-3	14897-14905	quantify	_
73-4	14906-14909	the	_
73-5	14910-14924	discriminative	_
73-6	14925-14930	power	_
73-7	14931-14933	of	_
73-8	14934-14935	a	_
73-9	14936-14939	GDM	_
73-10	14940-14941	,	_
73-11	14942-14945	and	_
73-12	14946-14950	thus	_
73-13	14951-14952	,	_
73-14	14953-14963	indirectly	_
73-15	14964-14965	,	_
73-16	14966-14969	the	_
73-17	14970-14975	whole	_
73-18	14976-14989	decomposition	_
73-19	14990-14991	,	_
73-20	14992-14994	by	_
73-21	14995-15005	generating	_
73-22	15006-15015	component	_
73-23	15016-15023	weights	_
73-24	15024-15026	in	_
73-25	15027-15028	a	_
73-26	15029-15035	nearly	_
73-27	15036-15045	identical	_
73-28	15046-15052	manner	_
73-29	15053-15055	to	_
73-30	15056-15059	the	_
73-31	15060-15063	GDM	_
73-32	15064-15071	spatial	_
73-33	15072-15076	maps	_
73-34	15077-15080	and	_
73-35	15081-15091	performing	_
73-36	15092-15093	a	_
73-37	15094-15104	two-sample	_
73-38	15105-15111	t-test	_
73-39	15112-15114	on	_
73-40	15115-15118	the	_
73-41	15119-15128	resulting	_
73-42	15129-15136	weights	_
73-43	15137-15138	.	_

Text=The corresponding component weights for the GDM are given by where is the subject covariation, obtained using ICA or IVA, corresponding to and, just as for, is multiplied by −1 if the sign of tn is negative.
74-1	15139-15142	The	_
74-2	15143-15156	corresponding	_
74-3	15157-15166	component	_
74-4	15167-15174	weights	_
74-5	15175-15178	for	_
74-6	15179-15182	the	_
74-7	15183-15186	GDM	_
74-8	15187-15190	are	_
74-9	15191-15196	given	_
74-10	15197-15199	by	_
74-11	15200-15205	where	_
74-12	15206-15208	is	_
74-13	15209-15212	the	_
74-14	15213-15220	subject	_
74-15	15221-15232	covariation	_
74-16	15233-15234	,	_
74-17	15235-15243	obtained	_
74-18	15244-15249	using	_
74-19	15250-15253	ICA	_
74-20	15254-15256	or	_
74-21	15257-15260	IVA	_
74-22	15261-15262	,	_
74-23	15263-15276	corresponding	_
74-24	15277-15279	to	_
74-25	15280-15283	and	_
74-26	15284-15285	,	_
74-27	15286-15290	just	_
74-28	15291-15293	as	_
74-29	15294-15297	for	_
74-30	15298-15299	,	_
74-31	15300-15302	is	_
74-32	15303-15313	multiplied	_
74-33	15314-15316	by	_
74-34	15317-15319	−1	_
74-35	15320-15322	if	_
74-36	15323-15326	the	_
74-37	15327-15331	sign	_
74-38	15332-15334	of	_
74-39	15335-15337	tn	_
74-40	15338-15340	is	_
74-41	15341-15349	negative	_
74-42	15350-15351	.	_

Text=This construction is expected to result in component loadings that show greater discriminatory power than the original, since is constructed from only those component loadings that are statistically significant.
75-1	15352-15356	This	_
75-2	15357-15369	construction	_
75-3	15370-15372	is	_
75-4	15373-15381	expected	_
75-5	15382-15384	to	_
75-6	15385-15391	result	_
75-7	15392-15394	in	_
75-8	15395-15404	component	_
75-9	15405-15413	loadings	_
75-10	15414-15418	that	_
75-11	15419-15423	show	_
75-12	15424-15431	greater	_
75-13	15432-15446	discriminatory	_
75-14	15447-15452	power	_
75-15	15453-15457	than	_
75-16	15458-15461	the	_
75-17	15462-15470	original	_
75-18	15471-15472	,	_
75-19	15473-15478	since	_
75-20	15479-15481	is	_
75-21	15482-15493	constructed	_
75-22	15494-15498	from	_
75-23	15499-15503	only	_
75-24	15504-15509	those	_
75-25	15510-15519	component	_
75-26	15520-15528	loadings	_
75-27	15529-15533	that	_
75-28	15534-15537	are	_
75-29	15538-15551	statistically	_
75-30	15552-15563	significant	_
75-31	15564-15565	.	_

Text=Additionally, the can be modeled as unit step functions with weights corresponding to their disease status and corrupted with Gaussian noise, where higher values of tn imply lower variances for the noise.
76-1	15566-15578	Additionally	_
76-2	15579-15580	,	_
76-3	15581-15584	the	_
76-4	15585-15588	can	_
76-5	15589-15591	be	_
76-6	15592-15599	modeled	_
76-7	15600-15602	as	_
76-8	15603-15607	unit	_
76-9	15608-15612	step	_
76-10	15613-15622	functions	_
76-11	15623-15627	with	_
76-12	15628-15635	weights	_
76-13	15636-15649	corresponding	_
76-14	15650-15652	to	_
76-15	15653-15658	their	_
76-16	15659-15666	disease	_
76-17	15667-15673	status	_
76-18	15674-15677	and	_
76-19	15678-15687	corrupted	_
76-20	15688-15692	with	_
76-21	15693-15701	Gaussian	_
76-22	15702-15707	noise	_
76-23	15708-15709	,	_
76-24	15710-15715	where	_
76-25	15716-15722	higher	_
76-26	15723-15729	values	_
76-27	15730-15732	of	_
76-28	15733-15735	tn	_
76-29	15736-15741	imply	_
76-30	15742-15747	lower	_
76-31	15748-15757	variances	_
76-32	15758-15761	for	_
76-33	15762-15765	the	_
76-34	15766-15771	noise	_
76-35	15772-15773	.	_

Text=Therefore, the summation of multiple, weighted as in (7), will tend to result in a lower value for the variance of the noise and, therefore, a more discriminative subject covariation.
77-1	15774-15783	Therefore	_
77-2	15784-15785	,	_
77-3	15786-15789	the	_
77-4	15790-15799	summation	_
77-5	15800-15802	of	_
77-6	15803-15811	multiple	_
77-7	15812-15813	,	_
77-8	15814-15822	weighted	_
77-9	15823-15825	as	_
77-10	15826-15828	in	_
77-11	15829-15830	(	_
77-12	15831-15832	7	_
77-13	15833-15834	)	_
77-14	15835-15836	,	_
77-15	15837-15841	will	_
77-16	15842-15846	tend	_
77-17	15847-15849	to	_
77-18	15850-15856	result	_
77-19	15857-15859	in	_
77-20	15860-15861	a	_
77-21	15862-15867	lower	_
77-22	15868-15873	value	_
77-23	15874-15877	for	_
77-24	15878-15881	the	_
77-25	15882-15890	variance	_
77-26	15891-15893	of	_
77-27	15894-15897	the	_
77-28	15898-15903	noise	_
77-29	15904-15907	and	_
77-30	15908-15909	,	_
77-31	15910-15919	therefore	_
77-32	15920-15921	,	_
77-33	15922-15923	a	_
77-34	15924-15928	more	_
77-35	15929-15943	discriminative	_
77-36	15944-15951	subject	_
77-37	15952-15963	covariation	_
77-38	15964-15965	.	_

Text=Additionally, note that the t-tests performed on the columns of the mixing matrices may be seen as a feature extraction step, thus corrections for multiple comparisons should only account for the number of GDMs calculated.
78-1	15966-15978	Additionally	_
78-2	15979-15980	,	_
78-3	15981-15985	note	_
78-4	15986-15990	that	_
78-5	15991-15994	the	_
78-6	15995-16002	t-tests	_
78-7	16003-16012	performed	_
78-8	16013-16015	on	_
78-9	16016-16019	the	_
78-10	16020-16027	columns	_
78-11	16028-16030	of	_
78-12	16031-16034	the	_
78-13	16035-16041	mixing	_
78-14	16042-16050	matrices	_
78-15	16051-16054	may	_
78-16	16055-16057	be	_
78-17	16058-16062	seen	_
78-18	16063-16065	as	_
78-19	16066-16067	a	_
78-20	16068-16075	feature	_
78-21	16076-16086	extraction	_
78-22	16087-16091	step	_
78-23	16092-16093	,	_
78-24	16094-16098	thus	_
78-25	16099-16110	corrections	_
78-26	16111-16114	for	_
78-27	16115-16123	multiple	_
78-28	16124-16135	comparisons	_
78-29	16136-16142	should	_
78-30	16143-16147	only	_
78-31	16148-16155	account	_
78-32	16156-16159	for	_
78-33	16160-16163	the	_
78-34	16164-16170	number	_
78-35	16171-16173	of	_
78-36	16174-16178	GDMs	_
78-37	16179-16189	calculated	_
78-38	16190-16191	.	_

Text=We should note that, by construction, the intensity of each voxel in a GDM is dependent on a linear combination of voxel values across components.
79-1	16192-16194	We	_
79-2	16195-16201	should	_
79-3	16202-16206	note	_
79-4	16207-16211	that	_
79-5	16212-16213	,	_
79-6	16214-16216	by	_
79-7	16217-16229	construction	_
79-8	16230-16231	,	_
79-9	16232-16235	the	_
79-10	16236-16245	intensity	_
79-11	16246-16248	of	_
79-12	16249-16253	each	_
79-13	16254-16259	voxel	_
79-14	16260-16262	in	_
79-15	16263-16264	a	_
79-16	16265-16268	GDM	_
79-17	16269-16271	is	_
79-18	16272-16281	dependent	_
79-19	16282-16284	on	_
79-20	16285-16286	a	_
79-21	16287-16293	linear	_
79-22	16294-16305	combination	_
79-23	16306-16308	of	_
79-24	16309-16314	voxel	_
79-25	16315-16321	values	_
79-26	16322-16328	across	_
79-27	16329-16339	components	_
79-28	16340-16341	.	_

Text=For this reason, the GDMs produced by algorithms that have fewer overlapping voxels across components are expected to be more easily interpretable.
80-1	16342-16345	For	_
80-2	16346-16350	this	_
80-3	16351-16357	reason	_
80-4	16358-16359	,	_
80-5	16360-16363	the	_
80-6	16364-16368	GDMs	_
80-7	16369-16377	produced	_
80-8	16378-16380	by	_
80-9	16381-16391	algorithms	_
80-10	16392-16396	that	_
80-11	16397-16401	have	_
80-12	16402-16407	fewer	_
80-13	16408-16419	overlapping	_
80-14	16420-16426	voxels	_
80-15	16427-16433	across	_
80-16	16434-16444	components	_
80-17	16445-16448	are	_
80-18	16449-16457	expected	_
80-19	16458-16460	to	_
80-20	16461-16463	be	_
80-21	16464-16468	more	_
80-22	16469-16475	easily	_
80-23	16476-16489	interpretable	_
80-24	16490-16491	.	_

Text=This is true for methods that promote sparsity, such as: Infomax, IVA-L, or dictionary learning.
81-1	16492-16496	This	_
81-2	16497-16499	is	_
81-3	16500-16504	true	_
81-4	16505-16508	for	_
81-5	16509-16516	methods	_
81-6	16517-16521	that	_
81-7	16522-16529	promote	_
81-8	16530-16538	sparsity	_
81-9	16539-16540	,	_
81-10	16541-16545	such	_
81-11	16546-16548	as	_
81-12	16549-16550	:	_
81-13	16551-16558	Infomax	_
81-14	16559-16560	,	_
81-15	16561-16566	IVA-L	_
81-16	16567-16568	,	_
81-17	16569-16571	or	_
81-18	16572-16582	dictionary	_
81-19	16583-16591	learning	_
81-20	16592-16593	.	_

Text=This is also true for methods that make few assumptions about the distribution of the latent sources, such as: EBM or SparseICA-EBM, in addition to methods that account for sample dependence between voxels, such as: weights-adjusted second-order blind identification as well as ICA and IVA using entropy-rate bound minimization.
82-1	16594-16598	This	_
82-2	16599-16601	is	_
82-3	16602-16606	also	_
82-4	16607-16611	true	_
82-5	16612-16615	for	_
82-6	16616-16623	methods	_
82-7	16624-16628	that	_
82-8	16629-16633	make	_
82-9	16634-16637	few	_
82-10	16638-16649	assumptions	_
82-11	16650-16655	about	_
82-12	16656-16659	the	_
82-13	16660-16672	distribution	_
82-14	16673-16675	of	_
82-15	16676-16679	the	_
82-16	16680-16686	latent	_
82-17	16687-16694	sources	_
82-18	16695-16696	,	_
82-19	16697-16701	such	_
82-20	16702-16704	as	_
82-21	16705-16706	:	_
82-22	16707-16710	EBM	_
82-23	16711-16713	or	_
82-24	16714-16727	SparseICA-EBM	_
82-25	16728-16729	,	_
82-26	16730-16732	in	_
82-27	16733-16741	addition	_
82-28	16742-16744	to	_
82-29	16745-16752	methods	_
82-30	16753-16757	that	_
82-31	16758-16765	account	_
82-32	16766-16769	for	_
82-33	16770-16776	sample	_
82-34	16777-16787	dependence	_
82-35	16788-16795	between	_
82-36	16796-16802	voxels	_
82-37	16803-16804	,	_
82-38	16805-16809	such	_
82-39	16810-16812	as	_
82-40	16813-16814	:	_
82-41	16815-16831	weights-adjusted	_
82-42	16832-16844	second-order	_
82-43	16845-16850	blind	_
82-44	16851-16865	identification	_
82-45	16866-16868	as	_
82-46	16869-16873	well	_
82-47	16874-16876	as	_
82-48	16877-16880	ICA	_
82-49	16881-16884	and	_
82-50	16885-16888	IVA	_
82-51	16889-16894	using	_
82-52	16895-16907	entropy-rate	_
82-53	16908-16913	bound	_
82-54	16914-16926	minimization	_
82-55	16927-16928	.	_

Text=A fundamental goal of neuroimaging studies is to understand the underlying neural basis for psychological measurements.
83-1	16929-16930	A	_
83-2	16931-16942	fundamental	_
83-3	16943-16947	goal	_
83-4	16948-16950	of	_
83-5	16951-16963	neuroimaging	_
83-6	16964-16971	studies	_
83-7	16972-16974	is	_
83-8	16975-16977	to	_
83-9	16978-16988	understand	_
83-10	16989-16992	the	_
83-11	16993-17003	underlying	_
83-12	17004-17010	neural	_
83-13	17011-17016	basis	_
83-14	17017-17020	for	_
83-15	17021-17034	psychological	_
83-16	17035-17047	measurements	_
83-17	17048-17049	.	_

Text=GDMs lend themselves to this goal in a straightforward manner and through their application can facilitate the discovery of which neuroimaging datasets most effectively explain the results of psychometric tests.
84-1	17050-17054	GDMs	_
84-2	17055-17059	lend	_
84-3	17060-17070	themselves	_
84-4	17071-17073	to	_
84-5	17074-17078	this	_
84-6	17079-17083	goal	_
84-7	17084-17086	in	_
84-8	17087-17088	a	_
84-9	17089-17104	straightforward	_
84-10	17105-17111	manner	_
84-11	17112-17115	and	_
84-12	17116-17123	through	_
84-13	17124-17129	their	_
84-14	17130-17141	application	_
84-15	17142-17145	can	_
84-16	17146-17156	facilitate	_
84-17	17157-17160	the	_
84-18	17161-17170	discovery	_
84-19	17171-17173	of	_
84-20	17174-17179	which	_
84-21	17180-17192	neuroimaging	_
84-22	17193-17201	datasets	_
84-23	17202-17206	most	_
84-24	17207-17218	effectively	_
84-25	17219-17226	explain	_
84-26	17227-17230	the	_
84-27	17231-17238	results	_
84-28	17239-17241	of	_
84-29	17242-17254	psychometric	_
84-30	17255-17260	tests	_
84-31	17261-17262	.	_

Text=This extension can be done by using the t-statistics derived from the correlations of the subject weights with the behavioral variables of interest, rather than those derived using the two-sample t-test.
85-1	17263-17267	This	_
85-2	17268-17277	extension	_
85-3	17278-17281	can	_
85-4	17282-17284	be	_
85-5	17285-17289	done	_
85-6	17290-17292	by	_
85-7	17293-17298	using	_
85-8	17299-17302	the	_
85-9	17303-17315	t-statistics	_
85-10	17316-17323	derived	_
85-11	17324-17328	from	_
85-12	17329-17332	the	_
85-13	17333-17345	correlations	_
85-14	17346-17348	of	_
85-15	17349-17352	the	_
85-16	17353-17360	subject	_
85-17	17361-17368	weights	_
85-18	17369-17373	with	_
85-19	17374-17377	the	_
85-20	17378-17388	behavioral	_
85-21	17389-17398	variables	_
85-22	17399-17401	of	_
85-23	17402-17410	interest	_
85-24	17411-17412	,	_
85-25	17413-17419	rather	_
85-26	17420-17424	than	_
85-27	17425-17430	those	_
85-28	17431-17438	derived	_
85-29	17439-17444	using	_
85-30	17445-17448	the	_
85-31	17449-17459	two-sample	_
85-32	17460-17466	t-test	_
85-33	17467-17468	.	_

Text=This means that the functional form of (6) and (7) would not change, instead tn would be defined based on the sample correlation and would be selected based on the significance of their correlation to the test score of interest.
86-1	17469-17473	This	_
86-2	17474-17479	means	_
86-3	17480-17484	that	_
86-4	17485-17488	the	_
86-5	17489-17499	functional	_
86-6	17500-17504	form	_
86-7	17505-17507	of	_
86-8	17508-17509	(	_
86-9	17510-17511	6	_
86-10	17512-17513	)	_
86-11	17514-17517	and	_
86-12	17518-17519	(	_
86-13	17520-17521	7	_
86-14	17522-17523	)	_
86-15	17524-17529	would	_
86-16	17530-17533	not	_
86-17	17534-17540	change	_
86-18	17541-17542	,	_
86-19	17543-17550	instead	_
86-20	17551-17553	tn	_
86-21	17554-17559	would	_
86-22	17560-17562	be	_
86-23	17563-17570	defined	_
86-24	17571-17576	based	_
86-25	17577-17579	on	_
86-26	17580-17583	the	_
86-27	17584-17590	sample	_
86-28	17591-17602	correlation	_
86-29	17603-17606	and	_
86-30	17607-17612	would	_
86-31	17613-17615	be	_
86-32	17616-17624	selected	_
86-33	17625-17630	based	_
86-34	17631-17633	on	_
86-35	17634-17637	the	_
86-36	17638-17650	significance	_
86-37	17651-17653	of	_
86-38	17654-17659	their	_
86-39	17660-17671	correlation	_
86-40	17672-17674	to	_
86-41	17675-17678	the	_
86-42	17679-17683	test	_
86-43	17684-17689	score	_
86-44	17690-17692	of	_
86-45	17693-17701	interest	_
86-46	17702-17703	.	_

Text=In this study, the behavioral variables were derived from the measurement and treatment research to improve cognition in schizophrenia (MATRICS) consensus cognitive battery (MCCB), which is widely recognized as a valuable tool that provides a comprehensive evaluation of cognitive function of schizophrenia within clinical trials.
87-1	17704-17706	In	_
87-2	17707-17711	this	_
87-3	17712-17717	study	_
87-4	17718-17719	,	_
87-5	17720-17723	the	_
87-6	17724-17734	behavioral	_
87-7	17735-17744	variables	_
87-8	17745-17749	were	_
87-9	17750-17757	derived	_
87-10	17758-17762	from	_
87-11	17763-17766	the	_
87-12	17767-17778	measurement	_
87-13	17779-17782	and	_
87-14	17783-17792	treatment	_
87-15	17793-17801	research	_
87-16	17802-17804	to	_
87-17	17805-17812	improve	_
87-18	17813-17822	cognition	_
87-19	17823-17825	in	_
87-20	17826-17839	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
87-21	17840-17841	(	_
87-22	17842-17849	MATRICS	_
87-23	17850-17851	)	_
87-24	17852-17861	consensus	_
87-25	17862-17871	cognitive	_
87-26	17872-17879	battery	_
87-27	17880-17881	(	_
87-28	17882-17886	MCCB	_
87-29	17887-17888	)	_
87-30	17889-17890	,	_
87-31	17891-17896	which	_
87-32	17897-17899	is	_
87-33	17900-17906	widely	_
87-34	17907-17917	recognized	_
87-35	17918-17920	as	_
87-36	17921-17922	a	_
87-37	17923-17931	valuable	_
87-38	17932-17936	tool	_
87-39	17937-17941	that	_
87-40	17942-17950	provides	_
87-41	17951-17952	a	_
87-42	17953-17966	comprehensive	_
87-43	17967-17977	evaluation	_
87-44	17978-17980	of	_
87-45	17981-17990	cognitive	_
87-46	17991-17999	function	_
87-47	18000-18002	of	_
87-48	18003-18016	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
87-49	18017-18023	within	_
87-50	18024-18032	clinical	_
87-51	18033-18039	trials	_
87-52	18040-18041	.	_

Text=Simulation Setup For real brain data, information about the true latent sources and subject weights is, generally, not known apriori.
88-1	18042-18052	Simulation	_
88-2	18053-18058	Setup	_
88-3	18059-18062	For	_
88-4	18063-18067	real	_
88-5	18068-18073	brain	_
88-6	18074-18078	data	_
88-7	18079-18080	,	_
88-8	18081-18092	information	_
88-9	18093-18098	about	_
88-10	18099-18102	the	_
88-11	18103-18107	true	_
88-12	18108-18114	latent	_
88-13	18115-18122	sources	_
88-14	18123-18126	and	_
88-15	18127-18134	subject	_
88-16	18135-18142	weights	_
88-17	18143-18145	is	_
88-18	18146-18147	,	_
88-19	18148-18157	generally	_
88-20	18158-18159	,	_
88-21	18160-18163	not	_
88-22	18164-18169	known	_
88-23	18170-18177	apriori	_
88-24	18178-18179	.	_

Text=Therefore, in order to demonstrate the efficacy of GDMs, we generate 5 simulated sources, shown in Figure 1.
89-1	18180-18189	Therefore	_
89-2	18190-18191	,	_
89-3	18192-18194	in	_
89-4	18195-18200	order	_
89-5	18201-18203	to	_
89-6	18204-18215	demonstrate	_
89-7	18216-18219	the	_
89-8	18220-18228	efficacy	_
89-9	18229-18231	of	_
89-10	18232-18236	GDMs	_
89-11	18237-18238	,	_
89-12	18239-18241	we	_
89-13	18242-18250	generate	_
89-14	18251-18252	5	_
89-15	18253-18262	simulated	_
89-16	18263-18270	sources	_
89-17	18271-18272	,	_
89-18	18273-18278	shown	_
89-19	18279-18281	in	_
89-20	18282-18288	Figure	_
89-21	18289-18290	1	_
89-22	18291-18292	.	_

Text=We then linearly mix the simulated latent sources with a simulated mixing matrix whose columns have a step-type characteristic corrupted by additive i.i.d.
90-1	18293-18295	We	_
90-2	18296-18300	then	_
90-3	18301-18309	linearly	_
90-4	18310-18313	mix	_
90-5	18314-18317	the	_
90-6	18318-18327	simulated	_
90-7	18328-18334	latent	_
90-8	18335-18342	sources	_
90-9	18343-18347	with	_
90-10	18348-18349	a	_
90-11	18350-18359	simulated	_
90-12	18360-18366	mixing	_
90-13	18367-18373	matrix	_
90-14	18374-18379	whose	_
90-15	18380-18387	columns	_
90-16	18388-18392	have	_
90-17	18393-18394	a	_
90-18	18395-18404	step-type	_
90-19	18405-18419	characteristic	_
90-20	18420-18429	corrupted	_
90-21	18430-18432	by	_
90-22	18433-18441	additive	_
90-23	18442-18447	i.i.d	_
90-24	18448-18449	.	_

Text=Gaussian noise, simulating a latent difference between two groups of subjects, each with 150 subjects in order to make the scenario similar to the real fMRI data used in this study.
91-1	18450-18458	Gaussian	_
91-2	18459-18464	noise	_
91-3	18465-18466	,	_
91-4	18467-18477	simulating	_
91-5	18478-18479	a	_
91-6	18480-18486	latent	_
91-7	18487-18497	difference	_
91-8	18498-18505	between	_
91-9	18506-18509	two	_
91-10	18510-18516	groups	_
91-11	18517-18519	of	_
91-12	18520-18528	subjects	_
91-13	18529-18530	,	_
91-14	18531-18535	each	_
91-15	18536-18540	with	_
91-16	18541-18544	150	_
91-17	18545-18553	subjects	_
91-18	18554-18556	in	_
91-19	18557-18562	order	_
91-20	18563-18565	to	_
91-21	18566-18570	make	_
91-22	18571-18574	the	_
91-23	18575-18583	scenario	_
91-24	18584-18591	similar	_
91-25	18592-18594	to	_
91-26	18595-18598	the	_
91-27	18599-18603	real	_
91-28	18604-18608	fMRI	_
91-29	18609-18613	data	_
91-30	18614-18618	used	_
91-31	18619-18621	in	_
91-32	18622-18626	this	_
91-33	18627-18632	study	_
91-34	18633-18634	.	_

Text=Thus, the equation for the columns of the mixing matrix is given by where ni is i.i.d.
92-1	18635-18639	Thus	_
92-2	18640-18641	,	_
92-3	18642-18645	the	_
92-4	18646-18654	equation	_
92-5	18655-18658	for	_
92-6	18659-18662	the	_
92-7	18663-18670	columns	_
92-8	18671-18673	of	_
92-9	18674-18677	the	_
92-10	18678-18684	mixing	_
92-11	18685-18691	matrix	_
92-12	18692-18694	is	_
92-13	18695-18700	given	_
92-14	18701-18703	by	_
92-15	18704-18709	where	_
92-16	18710-18712	ni	_
92-17	18713-18715	is	_
92-18	18716-18721	i.i.d	_
92-19	18722-18723	.	_

Text=white Gaussian noise, generated separately for each column, and ci is the step profile of size 1 for c1, 0.5 for c2, 0.26 for c3, 0.23 for c4, and 0 for c5.
93-1	18724-18729	white	_
93-2	18730-18738	Gaussian	_
93-3	18739-18744	noise	_
93-4	18745-18746	,	_
93-5	18747-18756	generated	_
93-6	18757-18767	separately	_
93-7	18768-18771	for	_
93-8	18772-18776	each	_
93-9	18777-18783	column	_
93-10	18784-18785	,	_
93-11	18786-18789	and	_
93-12	18790-18792	ci	_
93-13	18793-18795	is	_
93-14	18796-18799	the	_
93-15	18800-18804	step	_
93-16	18805-18812	profile	_
93-17	18813-18815	of	_
93-18	18816-18820	size	_
93-19	18821-18822	1	_
93-20	18823-18826	for	_
93-21	18827-18829	c1	_
93-22	18830-18831	,	_
93-23	18832-18835	0.5	_
93-24	18836-18839	for	_
93-25	18840-18842	c2	_
93-26	18843-18844	,	_
93-27	18845-18849	0.26	_
93-28	18850-18853	for	_
93-29	18854-18856	c3	_
93-30	18857-18858	,	_
93-31	18859-18863	0.23	_
93-32	18864-18867	for	_
93-33	18868-18870	c4	_
93-34	18871-18872	,	_
93-35	18873-18876	and	_
93-36	18877-18878	0	_
93-37	18879-18882	for	_
93-38	18883-18885	c5	_
93-39	18886-18887	.	_

Text=The differing values of the step height correspond to different average relative differences between the groups and range from high to no difference.
94-1	18888-18891	The	_
94-2	18892-18901	differing	_
94-3	18902-18908	values	_
94-4	18909-18911	of	_
94-5	18912-18915	the	_
94-6	18916-18920	step	_
94-7	18921-18927	height	_
94-8	18928-18938	correspond	_
94-9	18939-18941	to	_
94-10	18942-18951	different	_
94-11	18952-18959	average	_
94-12	18960-18968	relative	_
94-13	18969-18980	differences	_
94-14	18981-18988	between	_
94-15	18989-18992	the	_
94-16	18993-18999	groups	_
94-17	19000-19003	and	_
94-18	19004-19009	range	_
94-19	19010-19014	from	_
94-20	19015-19019	high	_
94-21	19020-19022	to	_
94-22	19023-19025	no	_
94-23	19026-19036	difference	_
94-24	19037-19038	.	_

Text=Note that since we know the value of the mean difference between the groups as well as the standard deviation of the samples (subjects), we are able to determine theoretical values for the t-statistics for each column of A.
95-1	19039-19043	Note	_
95-2	19044-19048	that	_
95-3	19049-19054	since	_
95-4	19055-19057	we	_
95-5	19058-19062	know	_
95-6	19063-19066	the	_
95-7	19067-19072	value	_
95-8	19073-19075	of	_
95-9	19076-19079	the	_
95-10	19080-19084	mean	_
95-11	19085-19095	difference	_
95-12	19096-19103	between	_
95-13	19104-19107	the	_
95-14	19108-19114	groups	_
95-15	19115-19117	as	_
95-16	19118-19122	well	_
95-17	19123-19125	as	_
95-18	19126-19129	the	_
95-19	19130-19138	standard	_
95-20	19139-19148	deviation	_
95-21	19149-19151	of	_
95-22	19152-19155	the	_
95-23	19156-19163	samples	_
95-24	19164-19165	(	_
95-25	19166-19174	subjects	_
95-26	19175-19176	)	_
95-27	19177-19178	,	_
95-28	19179-19181	we	_
95-29	19182-19185	are	_
95-30	19186-19190	able	_
95-31	19191-19193	to	_
95-32	19194-19203	determine	_
95-33	19204-19215	theoretical	_
95-34	19216-19222	values	_
95-35	19223-19226	for	_
95-36	19227-19230	the	_
95-37	19231-19243	t-statistics	_
95-38	19244-19247	for	_
95-39	19248-19252	each	_
95-40	19253-19259	column	_
95-41	19260-19262	of	_
95-42	19263-19264	A	_
95-43	19265-19266	.	_

Text=We then reduce the dimension of the dataset from 300 to 5 using PCA, perform ICA, and estimate a GDM.
96-1	19267-19269	We	_
96-2	19270-19274	then	_
96-3	19275-19281	reduce	_
96-4	19282-19285	the	_
96-5	19286-19295	dimension	_
96-6	19296-19298	of	_
96-7	19299-19302	the	_
96-8	19303-19310	dataset	_
96-9	19311-19315	from	_
96-10	19316-19319	300	_
96-11	19320-19322	to	_
96-12	19323-19324	5	_
96-13	19325-19330	using	_
96-14	19331-19334	PCA	_
96-15	19335-19336	,	_
96-16	19337-19344	perform	_
96-17	19345-19348	ICA	_
96-18	19349-19350	,	_
96-19	19351-19354	and	_
96-20	19355-19363	estimate	_
96-21	19364-19365	a	_
96-22	19366-19369	GDM	_
96-23	19370-19371	.	_

Text=The purpose of this simulation is twofold.
97-1	19372-19375	The	_
97-2	19376-19383	purpose	_
97-3	19384-19386	of	_
97-4	19387-19391	this	_
97-5	19392-19402	simulation	_
97-6	19403-19405	is	_
97-7	19406-19413	twofold	_
97-8	19414-19415	.	_

Text=First, we seek to demonstrate the utility of GDMs to visually summarize the results of a decomposition.
98-1	19416-19421	First	_
98-2	19422-19423	,	_
98-3	19424-19426	we	_
98-4	19427-19431	seek	_
98-5	19432-19434	to	_
98-6	19435-19446	demonstrate	_
98-7	19447-19450	the	_
98-8	19451-19458	utility	_
98-9	19459-19461	of	_
98-10	19462-19466	GDMs	_
98-11	19467-19469	to	_
98-12	19470-19478	visually	_
98-13	19479-19488	summarize	_
98-14	19489-19492	the	_
98-15	19493-19500	results	_
98-16	19501-19503	of	_
98-17	19504-19505	a	_
98-18	19506-19519	decomposition	_
98-19	19520-19521	.	_

Text=Second, to show how it is possible to use GDMs to relate the performance of different factorization methods.
99-1	19522-19528	Second	_
99-2	19529-19530	,	_
99-3	19531-19533	to	_
99-4	19534-19538	show	_
99-5	19539-19542	how	_
99-6	19543-19545	it	_
99-7	19546-19548	is	_
99-8	19549-19557	possible	_
99-9	19558-19560	to	_
99-10	19561-19564	use	_
99-11	19565-19569	GDMs	_
99-12	19570-19572	to	_
99-13	19573-19579	relate	_
99-14	19580-19583	the	_
99-15	19584-19595	performance	_
99-16	19596-19598	of	_
99-17	19599-19608	different	_
99-18	19609-19622	factorization	_
99-19	19623-19630	methods	_
99-20	19631-19632	.	_

Text=Towards this second aim, in this simulation, we compare the performance of two ICA methods, EBM and FastICA using the hyperbolic tangent nonlinearity.
100-1	19633-19640	Towards	_
100-2	19641-19645	this	_
100-3	19646-19652	second	_
100-4	19653-19656	aim	_
100-5	19657-19658	,	_
100-6	19659-19661	in	_
100-7	19662-19666	this	_
100-8	19667-19677	simulation	_
100-9	19678-19679	,	_
100-10	19680-19682	we	_
100-11	19683-19690	compare	_
100-12	19691-19694	the	_
100-13	19695-19706	performance	_
100-14	19707-19709	of	_
100-15	19710-19713	two	_
100-16	19714-19717	ICA	_
100-17	19718-19725	methods	_
100-18	19726-19727	,	_
100-19	19728-19731	EBM	_
100-20	19732-19735	and	_
100-21	19736-19743	FastICA	_
100-22	19744-19749	using	_
100-23	19750-19753	the	_
100-24	19754-19764	hyperbolic	_
100-25	19765-19772	tangent	_
100-26	19773-19785	nonlinearity	_
100-27	19786-19787	.	_

Text=We selected FastICA primarily because it is a popular method for the analysis of fMRI data, see e.g ..
101-1	19788-19790	We	_
101-2	19791-19799	selected	_
101-3	19800-19807	FastICA	_
101-4	19808-19817	primarily	_
101-5	19818-19825	because	_
101-6	19826-19828	it	_
101-7	19829-19831	is	_
101-8	19832-19833	a	_
101-9	19834-19841	popular	_
101-10	19842-19848	method	_
101-11	19849-19852	for	_
101-12	19853-19856	the	_
101-13	19857-19865	analysis	_
101-14	19866-19868	of	_
101-15	19869-19873	fMRI	_
101-16	19874-19878	data	_
101-17	19879-19880	,	_
101-18	19881-19884	see	_
101-19	19885-19888	e.g	_
101-20	19889-19891	..	_

Text=However, FastICA uses a fixed nonlinearity and so it may not able to fit a very wide variety of distributions meaning that the performance of FastICA may suffer when the distribution of the latent sources is different from the one implied by its nonlinearity.
102-1	19892-19899	However	_
102-2	19900-19901	,	_
102-3	19902-19909	FastICA	_
102-4	19910-19914	uses	_
102-5	19915-19916	a	_
102-6	19917-19922	fixed	_
102-7	19923-19935	nonlinearity	_
102-8	19936-19939	and	_
102-9	19940-19942	so	_
102-10	19943-19945	it	_
102-11	19946-19949	may	_
102-12	19950-19953	not	_
102-13	19954-19958	able	_
102-14	19959-19961	to	_
102-15	19962-19965	fit	_
102-16	19966-19967	a	_
102-17	19968-19972	very	_
102-18	19973-19977	wide	_
102-19	19978-19985	variety	_
102-20	19986-19988	of	_
102-21	19989-20002	distributions	_
102-22	20003-20010	meaning	_
102-23	20011-20015	that	_
102-24	20016-20019	the	_
102-25	20020-20031	performance	_
102-26	20032-20034	of	_
102-27	20035-20042	FastICA	_
102-28	20043-20046	may	_
102-29	20047-20053	suffer	_
102-30	20054-20058	when	_
102-31	20059-20062	the	_
102-32	20063-20075	distribution	_
102-33	20076-20078	of	_
102-34	20079-20082	the	_
102-35	20083-20089	latent	_
102-36	20090-20097	sources	_
102-37	20098-20100	is	_
102-38	20101-20110	different	_
102-39	20111-20115	from	_
102-40	20116-20119	the	_
102-41	20120-20123	one	_
102-42	20124-20131	implied	_
102-43	20132-20134	by	_
102-44	20135-20138	its	_
102-45	20139-20151	nonlinearity	_
102-46	20152-20153	.	_

Text=In contrast, as already mentioned in Section 2.3, EBM is able to fit a wide variety of distributions.
103-1	20154-20156	In	_
103-2	20157-20165	contrast	_
103-3	20166-20167	,	_
103-4	20168-20170	as	_
103-5	20171-20178	already	_
103-6	20179-20188	mentioned	_
103-7	20189-20191	in	_
103-8	20192-20199	Section	_
103-9	20200-20203	2.3	_
103-10	20204-20205	,	_
103-11	20206-20209	EBM	_
103-12	20210-20212	is	_
103-13	20213-20217	able	_
103-14	20218-20220	to	_
103-15	20221-20224	fit	_
103-16	20225-20226	a	_
103-17	20227-20231	wide	_
103-18	20232-20239	variety	_
103-19	20240-20242	of	_
103-20	20243-20256	distributions	_
103-21	20257-20258	.	_

Text=We present the results of this analysis in Figure 1.
104-1	20259-20261	We	_
104-2	20262-20269	present	_
104-3	20270-20273	the	_
104-4	20274-20281	results	_
104-5	20282-20284	of	_
104-6	20285-20289	this	_
104-7	20290-20298	analysis	_
104-8	20299-20301	in	_
104-9	20302-20308	Figure	_
104-10	20309-20310	1	_
104-11	20311-20312	.	_

Text=Note that in order to test the consistency of the results, those presented here are the result of 1,000 independent runs.
105-1	20313-20317	Note	_
105-2	20318-20322	that	_
105-3	20323-20325	in	_
105-4	20326-20331	order	_
105-5	20332-20334	to	_
105-6	20335-20339	test	_
105-7	20340-20343	the	_
105-8	20344-20355	consistency	_
105-9	20356-20358	of	_
105-10	20359-20362	the	_
105-11	20363-20370	results	_
105-12	20371-20372	,	_
105-13	20373-20378	those	_
105-14	20379-20388	presented	_
105-15	20389-20393	here	_
105-16	20394-20397	are	_
105-17	20398-20401	the	_
105-18	20402-20408	result	_
105-19	20409-20411	of	_
105-20	20412-20417	1,000	_
105-21	20418-20429	independent	_
105-22	20430-20434	runs	_
105-23	20435-20436	.	_

